Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADAM23	MDC3	ENSG00000114948	"ADAM metallopeptidase domain 23"	O75077	2	206443532-206621127	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;parathyroid gland: 82.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 410.0;Inhibitory neurons: 236.6;Oligodendrocyte precursor cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"memory CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 54.4;RH-30: 63.8;RPMI-8226: 172.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033276	Approved				"Secreted in brain"	NA	NA		890000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB033276: AB_2305247"	"unprognostic (7.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.03e-3)"	1.7	7.5	14.3	2.4	20.6	2.0	1.1	3.5	45.7	3.2	0.0	3.0	1.5	2.2	3.8	4.0	0.8	4.2	30.7	20.6	9.6	0.9	0.3	1.5	2.1	13.9	10.2	2.0	1.2	82.9	6.4	0.2	12.9	1.7	2.2	17.4	1.5	2.4	11.1	1.1	3.2	4.5	1.6	0.8	1.6	8.0	17.4	4.9	1.0	8.7	2.7	3.0	4.1	24.0	0.1	0.9	22.3	0.0	11.9	17.2	0.9	2.4	2.9	3.2	0.6	26.8	0.5	3.3	0.0	3.8	39.5	33.9	14.5	0.7	0.3	13.2	12.4	0.0	2.1	0.3	11.4	0.3	1.4	6.5	0.1	0.1	0.0	54.4	39.4	1.2	0.0	0.1	8.2	0.4	0.3	0.0	43.9	0.4	4.6	0.1	63.8	172.6	0.0	16.6	17.4	7.0	0.0	0.0	12.9	10.9	0.1	0.0	34.3	11.1	10.2	6.0	5.3	45.2	0.1	0.0	21.1	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	20.6	3.5	45.7	20.6	9.6	13.9	10.2	12.9	1.6	17.4	24.0	1.6	0.0	0.0	41.8	0.4	0.4	0.9	0.1	0.6	39.3	0.0	0.1	62.8	0.0	0.0	1.8	2.1	0.0	0.1	0.0	0.0	0.0	17.6	0.3	7.7	2.7	1.8	0.0	410.0	0.0	0.0	4.3	0.0	0.2	0.0	15.0	0.0	0.1	0.0	3.3	236.6	0.0	0.0	0.0	0.3	57.7	0.6	0.1	3.6	10.3	0.0	4.1	0.0	127.2	22.3	0.1	1.1	3.0	0.0	0.5	0.0	0.0	0.7	6.8	0.0	14.2	2.2	5.1	4.7	1.5	0.4	0.1	2.0	45.2	0.0	0.1
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;ovary: 10.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 7.3;Excitatory neurons: 44.7;Fibroblasts: 13.7;Granulosa cells: 22.2;Theca cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.9;SuSa: 3.5;U-2197: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	5.4	0.2	1.4	0.4	1.9	0.5	0.7	17.0	2.6	1.4	0.0	0.7	0.6	1.3	1.6	1.5	0.7	6.4	0.2	3.4	0.0	3.5	0.4	0.7	0.2	0.2	0.2	10.4	4.5	0.1	0.0	0.2	0.7	0.1	0.3	1.2	0.2	0.5	0.2	0.4	0.5	1.1	0.0	0.2	0.2	0.4	0.0	0.2	0.3	0.2	0.1	1.0	0.6	1.8	1.7	1.7	1.7	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.5	0.0	1.4	0.1	2.1	0.0	3.0	0.1	0.0	0.0	0.4	0.1	0.9	0.3	2.8	0.0	0.0	0.2	0.0	0.0	0.0	3.9	0.1	0.5	0.0	0.3	0.6	0.4	0.7	0.0	0.4	0.2	1.1	0.0	1.6	0.4	2.2	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	3.5	0.1	0.1	0.1	2.1	3.0	5.8	1.4	0.9	0.3	0.1	3.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	1.9	17.0	2.6	3.4	0.0	0.2	0.2	0.7	0.0	0.0	1.8	0.7	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.6	2.0	0.7	0.4	0.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	5.0	0.1	0.0	0.0	44.7	0.0	0.0	13.7	0.5	0.5	0.0	22.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	6.9	1.6	0.1	0.0	0.0	0.0	0.0	0.1	15.9	0.0	0.0
ADGRB3	"BAI3, KIAA0550"	ENSG00000135298	"Adhesion G protein-coupled receptor B3"	O60242	6	68635282-69389506	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.6;pituitary gland: 23.7"	"Group enriched"	"Detected in some"	10	"Astrocytes: 1795.3;Excitatory neurons: 3843.1;Inhibitory neurons: 2738.1;Oligodendrocyte precursor cells: 2036.3;Oligodendrocytes: 1210.5"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 8.8;SH-SY5Y: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		8600		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.08e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.16e-3)"	0.8	3.9	21.1	0.8	25.5	0.0	0.6	49.6	29.7	1.3	0.0	4.3	0.4	2.2	0.9	0.7	0.9	0.9	1.9	31.1	12.1	1.0	0.5	1.7	0.0	0.0	0.6	1.6	0.3	0.1	23.7	0.1	1.1	1.0	1.3	7.1	1.2	1.4	0.3	0.4	1.4	3.3	0.0	0.6	1.3	1.9	18.2	0.1	0.8	1.4	0.0	2.6	1.4	19.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.0	1.2	1.0	0.0	0.0	8.8	19.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	21.1	25.5	49.6	29.7	31.1	12.1	0.0	0.6	1.1	0.0	18.2	19.1	3.1	0.0	0.0	1795.3	0.3	0.0	0.1	0.0	0.0	47.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.2	4.8	0.6	0.0	0.0	3843.1	0.0	0.0	2.1	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	2738.1	0.0	0.0	0.6	0.0	3.1	5.0	1.3	0.0	216.4	1.0	0.8	0.0	2036.3	1210.5	0.1	0.0	8.6	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.6	7.4	11.8	3.2	0.2	0.0	0.0	0.0	0.5	0.0	0.1
ANGPT1	"Ang1, KIAA0003"	ENSG00000154188	"Angiopoietin 1"	Q15389	8	107249482-107498055	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 33.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 60.4;Fibroblasts: 20.4;Inhibitory neurons: 37.6;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 5.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 87.9;HEL: 53.1;HSkMC: 145.5;U-138 MG: 70.5;WM-115: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017815, HPA018793, HPA018816"	Approved				"Secreted to blood"	NA	NA	32000000	110000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.40e-4)"	"unprognostic (4.56e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	25.1	5.6	3.2	2.6	4.5	0.7	4.6	4.5	2.2	5.8	2.5	3.4	2.3	3.5	4.8	3.5	3.0	13.2	4.8	4.5	6.1	11.1	2.1	21.7	1.4	8.0	3.5	9.5	1.6	1.2	5.8	20.5	4.8	17.7	3.3	0.6	12.0	33.5	23.4	1.2	2.6	3.3	4.8	11.0	4.0	2.3	2.1	2.1	3.5	7.0	1.0	3.9	3.7	11.9	0.0	2.4	9.3	5.3	87.9	30.2	6.6	30.0	25.8	8.1	11.9	6.2	0.1	0.0	0.1	16.0	0.0	0.0	4.2	0.1	10.5	0.0	1.4	53.1	0.6	0.0	24.5	0.7	0.0	145.5	0.0	4.9	0.6	7.5	0.6	0.0	28.2	5.1	10.9	0.0	1.1	7.9	9.6	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.1	4.2	1.1	0.6	0.0	11.6	2.2	0.0	0.3	70.5	0.9	2.5	0.7	0.2	3.2	0.0	9.7	1.1	47.5	0.1	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.0	0.6	3.2	4.5	4.5	2.2	4.5	6.1	8.0	3.5	4.8	4.8	2.1	11.9	9.0	0.0	2.3	60.4	0.0	0.6	10.1	0.4	5.2	0.9	0.5	2.8	3.3	0.0	2.2	7.3	0.0	5.2	0.0	0.0	1.9	0.3	8.1	0.7	9.1	5.6	0.0	10.1	6.5	0.0	7.6	20.4	1.5	1.9	0.0	0.0	3.3	0.1	0.5	0.0	37.6	0.0	2.0	0.3	1.0	2.4	2.5	2.9	0.0	6.5	1.5	0.5	0.0	3.0	0.6	0.0	0.0	3.8	1.1	1.2	0.0	2.8	0.8	0.0	6.6	3.5	48.6	1.6	5.4	4.0	0.1	2.7	0.8	1.7	0.1	1.2
ARMH4	"C14orf37, UT2"	ENSG00000139971	"Armadillo like helical domain containing 4"	Q86TY3	14	57999735-58298139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8;kidney: 8.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 15.8;Collecting duct cells: 12.9;Endometrial ciliated cells: 10.2;Endometrial stromal cells: 7.7;Granulosa cells: 26.0;Theca cells: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.7;AN3-CA: 6.1;fHDF/TERT166: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001580, HPA001789"	Enhanced		Approved	"Plasma membrane"		NA	NA		1800000		"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"		"HPA001580: AB_2666366, HPA001789: AB_1078328"	"unprognostic (2.56e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.87e-8)"	"unprognostic (5.22e-6)"	"unprognostic (4.93e-2)"	"unprognostic (8.74e-4)"	"unprognostic (3.01e-4)"	1.2	2.5	2.3	0.6	3.6	0.7	0.8	8.5	3.5	1.8	0.0	0.7	0.5	3.0	1.8	0.8	2.1	1.8	3.1	2.6	2.1	8.3	0.8	0.7	0.4	11.5	5.1	4.3	1.0	3.6	1.3	0.4	12.8	1.6	1.0	1.2	0.7	1.4	0.2	1.0	0.7	2.3	1.0	0.5	1.4	2.2	1.6	0.2	1.5	1.9	0.3	1.2	0.9	0.7	0.0	0.0	9.7	6.1	4.7	1.7	0.0	1.9	1.5	0.3	0.3	0.5	0.1	0.0	0.6	10.8	1.2	0.0	2.9	0.0	0.4	0.1	1.0	0.0	0.0	0.5	0.2	0.0	4.8	1.8	0.0	0.2	0.2	2.7	0.5	0.8	0.1	0.3	1.2	0.3	0.0	0.0	4.5	0.0	2.0	1.4	0.3	2.5	3.9	0.3	1.1	0.0	0.1	0.0	0.3	2.7	0.2	0.2	0.1	1.3	3.5	0.5	2.6	0.3	0.2	0.0	3.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.6	8.5	3.5	2.6	2.1	11.5	5.1	12.8	1.0	1.6	0.7	15.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	12.9	0.0	0.2	0.7	0.0	0.0	2.1	0.0	10.2	7.7	2.3	0.0	0.0	0.0	1.3	0.4	3.0	0.0	2.4	0.0	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.3	44.5	0.0	0.0
BACE2	"AEPLC, ALP56, CEAP1, DRAP"	ENSG00000182240	"Beta-secretase 2"	Q9Y5Z0	21	41167801-41282530	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 290.4;Syncytiotrophoblasts: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;eosinophil: 5.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"OE19: 73.8;SK-BR-3: 53.3;SK-MEL-30: 52.6;WM-115: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035416	Approved				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA035416: AB_2732467"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.23e-2)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.64e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.83e-2)"	10.0	1.6	2.1	4.3	3.1	0.6	7.7	4.4	2.6	6.1	9.4	7.3	3.5	8.7	1.9	9.4	6.3	8.3	6.2	2.0	4.1	9.8	1.7	4.3	3.1	6.7	3.8	2.7	13.1	2.3	1.5	2.9	5.1	8.3	4.5	0.3	26.8	2.6	2.2	5.0	4.5	4.7	5.5	4.7	22.9	1.0	4.1	1.1	4.6	2.2	3.6	6.7	5.6	8.7	27.4	2.1	12.6	0.0	2.5	2.1	0.1	6.3	0.0	3.9	3.8	0.0	9.6	0.1	12.2	7.1	7.2	8.1	0.0	13.6	1.4	0.0	12.6	6.2	3.3	0.0	1.0	0.0	14.4	5.5	2.8	0.5	2.7	20.9	12.1	6.4	0.0	0.1	6.0	6.1	3.4	0.0	8.5	73.8	12.1	1.0	0.0	9.8	11.5	2.5	0.4	0.1	0.5	53.3	52.6	1.0	12.0	0.1	15.8	7.3	5.3	6.5	10.9	0.1	0.1	0.0	17.8	0.0	46.2	2.9	0.0	5.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	3.1	4.4	2.6	2.0	4.1	6.7	3.8	5.1	5.5	4.1	8.7	55.0	12.8	15.9	11.8	28.6	18.5	91.6	25.6	42.7	0.8	40.3	33.8	9.7	123.0	72.5	20.2	2.1	127.6	0.5	40.5	93.9	146.3	24.3	65.4	19.8	90.2	18.5	22.1	11.7	105.2	64.2	34.0	186.6	115.8	90.7	6.7	35.3	1.0	28.0	0.0	7.5	86.2	44.7	17.0	8.2	16.0	14.3	3.6	179.7	20.6	2.9	3.1	0.0	9.5	46.0	86.6	23.9	18.8	3.2	290.4	7.3	1.4	76.5	0.8	0.0	15.9	23.6	0.6	1.4	43.5	11.8	514.7	6.2	8.7	56.6	134.2
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677510-28682932	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 81.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 174.7;Breast myoepithelial cells: 163.2;Granulosa cells: 334.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 166.7;SK-MEL-30: 199.0;SuSa: 357.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nucleoli fibrillar center, Lipid droplets"	"HPA010819: AB_2668371, HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	4.4	44.1	13.8	2.3	16.3	6.0	23.7	18.4	17.6	5.7	20.7	3.8	1.6	17.9	2.9	2.1	6.3	5.4	43.5	13.6	15.9	19.9	23.9	12.0	2.0	19.9	16.9	81.6	6.9	8.2	8.5	39.3	21.1	7.4	4.7	13.4	6.4	16.7	1.8	5.4	2.1	12.2	16.6	18.0	3.8	8.7	14.8	0.4	1.2	1.9	1.4	30.0	5.4	22.7	1.0	41.0	4.2	2.2	4.8	0.1	24.5	9.7	3.5	15.4	10.0	166.7	17.3	0.5	5.7	7.4	8.8	12.2	10.2	1.6	7.2	10.1	21.0	39.5	6.2	63.7	5.9	2.4	51.5	3.7	2.3	10.4	1.6	96.7	2.4	2.1	22.1	18.7	3.1	70.1	0.2	3.3	71.6	34.5	9.9	0.3	7.8	3.6	12.9	40.4	6.8	5.2	13.2	78.5	199.0	357.8	23.2	3.0	0.3	10.4	7.3	17.0	4.7	0.5	15.0	0.0	1.0	8.9	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.3	18.4	17.6	13.6	15.9	19.9	16.9	21.1	16.6	14.8	22.7	6.6	9.6	5.9	15.0	5.7	4.0	7.6	0.6	13.1	14.3	174.7	163.2	34.9	58.6	3.5	11.0	4.2	12.0	9.3	33.8	1.9	20.8	0.1	14.3	15.3	7.3	26.8	0.0	0.5	0.2	22.2	46.1	58.6	21.1	1.3	334.8	14.6	16.0	6.7	6.7	0.2	3.8	0.0	1.6	4.2	1.2	3.4	5.4	16.0	15.9	0.7	50.2	0.0	46.3	21.2	12.1	34.6	2.2	4.3	10.8	1.1	16.1	1.4	5.9	0.0	4.2	42.7	1.9	15.5	13.5	1.3	8.5	7.8	6.2	3.8	14.1
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2915.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 276.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2"	"Not detected"	"Not detected"							"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	416.4	136.1	26.4	207.7	28.5	1.7	252.5	27.1	43.1	309.2	36.7	192.4	84.6	209.0	147.2	152.9	315.4	543.8	191.5	25.4	34.8	60.2	2915.2	224.9	209.2	44.3	31.7	485.9	62.1	21.8	33.1	52.9	31.2	174.4	215.2	9.7	96.9	139.1	57.0	104.1	154.2	251.8	30.9	168.5	150.1	90.0	30.9	88.1	139.0	154.7	192.5	455.7	189.8	31.3	0.2	18.6	1.2	10.2	769.5	1012.7	4.5	143.3	336.1	74.7	135.7	0.9	2.0	0.5	19.7	179.6	20.2	1.1	0.3	2.1	6.7	0.7	0.7	0.5	5.6	48.2	230.3	1.8	0.9	540.2	2.8	60.2	4.4	94.2	0.1	0.2	0.4	0.1	9.9	0.0	0.4	1.6	10.3	0.0	0.6	0.2	1.1	1.5	3.1	2.5	0.8	0.9	86.6	1.8	2.1	17.4	0.1	0.0	0.5	34.2	2.6	133.8	0.2	0.6	0.5	0.8	73.6	1.2	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	26.4	28.5	27.1	43.1	25.4	34.8	44.3	31.7	31.2	30.9	30.9	31.3	37.6	16.0	41.0	9.4	5.7	76.2	18.9	22.2	23.9	0.9	4.5	15.4	21.5	171.6	15.5	3.7	0.0	3.7	0.7	0.1	1.9	285.2	6.6	8.7	272.4	30.6	0.0	112.2	2.9	42.9	2.5	687.0	11.2	7.3	5.1	25.7	93.5	2795.1	8.1	5.0	1.7	0.0	2.0	62.8	103.7	29.9	1193.2	6.4	88.9	19.7	1.0	15.2	0.0	1.5	0.6	31.7	0.1	640.1	1.8	9.7	0.0	7.1	4.6	1.1	138.1	34.9	127.6	6.3	5.3	6.3	53.8	2.6	12.8	30.7	0.2	5.2
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 4761.3"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 4512.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 1213.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"non-classical monocyte: 13.3"	"Lineage enriched"	"Detected in many"	4	"monocytes: 13.3"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 357.8;EFO-21: 738.6;Hep G2: 795.3;HSkMC: 534.8;SiHa: 209.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	NA	NA	1260000000000	200000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	585.2	286.5	46.0	194.3	53.7	1.5	213.9	47.8	46.0	237.5	31.5	128.9	22.9	82.9	41.1	76.4	350.3	354.9	221.6	36.5	81.8	51.4	4761.3	176.0	68.2	143.3	99.2	228.1	182.7	17.9	21.8	17.7	116.4	35.4	76.5	11.7	155.6	57.4	36.6	51.4	156.4	123.0	89.9	7.1	107.9	41.1	103.4	34.1	92.4	52.0	126.4	363.3	101.3	121.9	65.0	23.0	0.0	0.1	10.8	36.0	74.7	5.2	357.8	6.8	12.6	3.6	49.5	1.9	738.6	0.3	54.2	46.6	0.2	43.1	6.9	24.0	0.5	3.1	31.2	795.3	16.3	6.2	9.1	534.8	12.8	60.8	27.3	9.5	0.0	0.0	2.1	0.8	0.2	1.0	0.6	1.6	1.5	0.7	0.1	0.4	5.0	0.3	32.1	6.2	0.5	0.5	209.5	0.1	0.5	0.1	17.2	8.8	3.5	5.7	7.4	4.8	3.6	1.6	4.8	4.5	75.1	4.5	0.3	1.7	1.3	0.6	0.3	2.5	0.2	0.5	0.2	0.1	0.7	0.5	0.2	0.2	3.0	1.3	13.3	0.5	0.1	0.9	46.0	53.7	47.8	46.0	36.5	81.8	143.3	99.2	116.4	89.9	103.4	121.9	36.4	76.9	473.9	0.7	29.4	27.5	14.7	141.5	0.6	0.7	19.5	23.4	14.5	783.5	422.5	16.5	0.0	1.4	2.0	0.2	5.9	494.1	45.9	23.0	63.5	26.2	0.0	209.9	0.4	136.7	1.4	482.2	17.9	57.7	5.1	0.1	124.9	4512.2	34.4	0.0	0.5	0.9	20.3	164.5	44.8	97.5	226.2	45.1	35.6	70.3	14.6	1.2	0.0	0.5	0.6	376.4	0.2	10.9	3.9	13.3	1.9	53.6	177.5	4.6	6.6	20.1	49.1	4.0	7.7	5.2	21.9	2.7	15.0	0.1	0.4	38.2
C7		ENSG00000112936	"Complement C7"	P10643	5	40909497-40984643	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 735.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 578.4;Hepatic stellate cells: 662.5;Leydig cells: 1058.5;Sertoli cells: 309.0;Theca cells: 503.1"	"Cancer enriched"	"Detected in all"	4	"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 116.5;HHSteC: 155.1;HSkMC: 212.1;SH-SY5Y: 146.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"spinal cord: 13.7"	HPA001465	Approved				"Secreted to blood"	NA	NA		48000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favorable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	470.9	607.7	2.6	21.7	3.5	0.2	46.4	2.6	9.6	118.5	13.6	165.3	19.3	124.6	163.6	52.9	377.3	211.7	558.7	2.8	2.5	298.1	110.6	206.7	99.2	4.4	2.7	735.4	149.8	15.0	23.1	359.2	3.0	101.6	32.5	1.5	18.0	105.7	4.3	12.6	139.8	256.3	4.3	138.2	120.2	28.0	3.0	32.2	105.1	1.6	22.5	122.1	118.3	3.0	0.0	0.0	0.0	0.0	116.5	16.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	155.1	0.0	0.0	212.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	146.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.6	3.5	2.6	9.6	2.8	2.5	4.4	2.7	3.0	4.3	3.0	3.0	7.9	6.4	4.1	0.0	1.4	0.6	0.5	0.0	1.8	2.1	1.2	0.3	56.7	7.2	2.5	0.0	0.0	0.2	0.1	0.4	0.0	0.2	4.7	0.5	7.9	127.6	54.8	26.7	0.1	1.3	0.1	578.4	0.0	0.2	1.3	2.7	662.5	8.3	0.5	43.7	0.3	1.3	0.0	14.5	4.2	29.8	1058.5	1.5	0.0	58.1	0.6	3.7	0.0	0.0	0.0	0.9	0.9	18.0	1.0	1.3	0.2	0.1	0.0	0.9	309.0	2.2	23.7	2.6	2.5	6.5	0.6	0.3	1.2	503.1	3.0	0.8
CADM3	"BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1"	ENSG00000162706	"Cell adhesion molecule 3"	Q8N126	1	159171609-159203313	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 151.6;placenta: 80.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 146.4;Excitatory neurons: 35.5;Fibroblasts: 39.5;Horizontal cells: 35.3;Inhibitory neurons: 40.5;Muller glia cells: 39.4"	"Cancer enriched"	"Detected in many"	4	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 65.0;HSkMC: 218.8;hTERT-HME1: 118.5;WM-115: 60.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002981, CAB025746"	Enhanced	Supported			"Intracellular and membrane"	NA	NA		800000		"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025746: , HPA002981: AB_1078916"	"unprognostic (1.74e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.12e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (5.52e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (5.75e-4)"	17.3	7.9	102.0	15.1	139.6	0.1	9.2	151.6	145.4	27.6	1.2	28.2	4.4	3.9	1.3	11.5	9.2	6.2	18.1	143.1	96.2	2.2	0.6	5.0	14.3	87.4	84.1	1.5	2.2	0.2	31.0	80.6	120.7	5.1	14.4	66.8	5.9	4.7	2.3	13.0	15.8	6.1	66.3	13.3	11.1	3.0	99.4	1.2	7.3	6.5	9.8	16.2	31.0	60.8	0.0	0.0	0.6	0.0	4.2	1.2	0.0	0.0	0.0	9.4	1.8	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.0	0.0	3.8	0.0	0.0	3.7	0.0	0.0	65.0	0.0	0.2	218.8	0.0	0.1	118.5	0.0	5.3	0.0	0.0	0.2	2.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	4.1	0.0	0.0	5.0	0.0	0.1	9.1	0.0	32.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.0	139.6	151.6	145.4	143.1	96.2	87.4	84.1	120.7	66.3	99.4	60.8	4.2	0.0	0.5	11.4	0.0	6.6	0.1	0.0	0.6	146.4	0.1	0.8	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.0	0.0	0.2	8.0	0.0	0.0	35.5	0.0	0.8	39.5	0.5	0.0	0.0	0.0	3.6	0.0	1.2	35.3	40.5	0.0	0.0	0.0	10.7	8.3	0.6	0.3	24.9	1.9	0.0	39.4	0.0	18.6	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	16.3	3.6	3.1	2.6	0.3	4.3	0.7	0.6	0.0	0.0	0.1
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 75.1;Fibroblasts: 38.2;Hepatic stellate cells: 48.2;Hofbauer cells: 53.7;Leydig cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 45.1;BJ: 37.7;BJ hTERT+: 37.5;fHDF/TERT166: 43.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	49.7	18.5	7.2	12.5	6.5	2.1	38.9	6.3	9.0	54.4	7.0	18.4	6.5	58.1	5.5	12.2	43.3	21.6	34.2	7.0	7.3	10.7	4.5	23.2	13.7	8.0	6.4	48.1	7.1	3.1	7.3	10.0	7.8	21.1	4.3	0.4	14.9	10.6	9.7	17.9	19.6	15.9	7.7	35.3	13.8	11.5	8.0	5.6	21.6	11.1	6.1	33.9	39.3	7.9	11.0	7.5	1.8	2.4	27.3	45.1	9.1	37.7	37.5	11.2	15.7	3.3	5.3	3.3	4.2	43.2	0.7	5.0	3.8	0.0	2.1	0.4	21.5	7.8	2.5	0.6	12.4	1.3	0.7	15.6	0.0	3.3	0.1	20.8	13.5	8.3	1.8	19.8	7.5	25.0	3.0	3.7	4.8	2.3	6.7	9.2	3.0	7.5	1.0	0.9	5.3	2.3	1.5	6.2	2.1	0.8	1.2	2.5	24.5	3.6	4.4	12.6	2.7	3.0	7.6	3.8	31.0	24.0	0.8	70.0	91.9	1.8	83.7	178.4	69.6	27.7	56.5	69.7	152.1	7.3	10.8	42.3	3.6	62.9	214.6	17.8	82.7	85.6	7.2	6.5	6.3	9.0	7.0	7.3	8.0	6.4	7.8	7.7	8.0	7.9	18.2	3.2	0.6	1.0	4.9	5.4	2.9	0.6	4.0	0.1	3.4	4.4	3.3	1.5	0.0	3.7	0.0	3.1	11.3	0.1	0.0	4.2	1.0	1.4	19.8	25.5	1.2	5.7	2.3	0.2	75.1	38.2	1.5	2.1	8.8	11.4	48.2	0.6	53.7	0.0	0.5	0.1	2.0	28.8	18.8	2.5	45.7	21.5	8.8	2.8	17.3	0.2	33.0	1.0	0.2	0.1	0.1	16.1	3.1	0.8	0.0	0.3	0.0	0.1	19.7	16.8	27.9	0.8	0.9	0.8	3.8	19.2	19.4	6.0	0.0	1.0
CAMK2N1	CaMKIINalpha	ENSG00000162545	"Calcium/calmodulin dependent protein kinase II inhibitor 1"	Q7Z7J9	1	20482391-20486210	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 461.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 640.5;Intestinal goblet cells: 431.4;Paneth cells: 367.7;Proximal tubular cells: 519.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;MAIT T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 212.1;CAPAN-2: 199.1;Hep G2: 165.6;SK-BR-3: 159.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075200	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA075200: "	"unprognostic (1.67e-1)"	"unprognostic (2.70e-3)"	"unprognostic (9.71e-3)"	"unprognostic (3.13e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (1.37e-7)"	"prognostic unfavorable (5.49e-4)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-2)"	20.1	61.6	340.5	9.3	322.3	0.5	19.8	172.0	461.3	32.5	115.4	85.0	80.4	27.8	38.1	27.8	22.3	27.4	22.3	354.6	206.5	86.2	53.8	67.9	1.9	224.8	222.4	30.2	8.8	42.4	37.7	11.6	215.9	35.8	77.0	32.6	30.4	40.8	7.1	12.0	86.9	22.7	226.7	12.2	19.5	4.7	265.4	2.0	10.8	9.9	7.0	27.3	24.3	348.6	63.1	17.5	15.0	212.1	28.4	52.6	2.2	52.6	119.0	9.5	4.8	20.1	199.1	6.3	14.7	21.7	7.7	103.2	4.6	90.0	5.9	11.7	3.8	1.3	0.9	165.6	31.4	0.1	6.2	8.4	41.2	5.6	21.2	19.6	16.4	4.3	6.3	0.5	105.8	17.4	0.2	0.5	2.8	109.7	3.9	5.6	9.4	0.4	59.3	93.5	57.6	16.2	28.5	159.6	16.3	10.2	30.6	0.6	5.0	34.9	46.1	48.5	21.1	0.1	0.1	2.5	119.5	13.5	22.0	0.0	0.0	0.0	1.6	0.0	1.1	0.5	0.5	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	340.5	322.3	172.0	461.3	354.6	206.5	224.8	222.4	215.9	226.7	265.4	348.6	28.3	3.2	1.1	35.6	7.6	9.3	11.7	2.3	0.6	248.6	96.5	104.5	20.8	178.7	2.5	248.3	6.2	0.5	10.1	640.5	229.0	20.1	0.8	6.2	45.6	20.0	299.2	8.0	132.5	40.8	2.9	65.1	9.2	12.0	1.3	4.6	9.3	201.6	0.3	85.8	108.7	431.4	14.2	1.9	12.1	3.9	62.7	5.6	39.2	26.2	0.6	81.1	0.0	27.6	249.1	141.5	367.7	94.0	3.5	37.7	183.2	519.2	1.2	35.6	131.5	86.2	96.4	0.8	2.8	1.0	7.5	2.1	14.7	0.8	223.5	50.3
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430939-59697662	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 33.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.1;Rod photoreceptor cells: 38.2;Theca cells: 78.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"BJ: 101.2;BJ hTERT+: 103.2;BJ hTERT+ SV40 Large T+ RasG12V: 96.4;HBF TERT88: 113.3;hTERT-HME1: 153.2;LHCN-M2: 176.9;TIME: 93.3"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 2.7;hippocampal formation: 8.7"	"Low region specificity"	"Detected in many"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	4.1	10.2	2.7	1.2	3.4	0.5	1.8	2.2	3.0	10.5	0.7	16.7	1.1	6.9	0.5	2.8	8.3	1.3	2.1	6.5	1.1	3.3	5.7	9.9	1.3	0.2	1.9	33.5	1.1	2.9	0.4	0.5	0.3	2.4	2.8	1.1	0.6	4.0	15.3	3.0	2.5	3.2	0.2	0.5	1.6	0.6	3.7	1.2	0.9	0.9	0.7	0.8	1.3	1.5	20.6	1.9	0.0	0.2	15.1	47.2	30.7	101.2	103.2	73.5	96.4	0.3	0.3	0.4	0.2	40.6	16.7	2.3	0.2	65.5	113.3	0.4	0.3	0.2	0.4	0.3	35.1	0.3	0.2	32.0	2.9	57.0	153.2	31.2	3.6	0.3	0.2	0.5	176.9	0.6	0.1	0.2	0.3	0.0	0.6	0.1	0.2	0.2	3.9	2.0	0.4	0.7	0.3	0.2	0.9	7.2	0.3	0.5	93.3	0.2	10.0	15.3	0.3	0.3	0.3	0.2	5.0	0.3	2.4	9.2	0.2	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.5	0.4	0.1	0.2	0.1	0.1	2.7	3.4	2.2	3.0	6.5	1.1	0.2	1.9	0.3	0.2	3.7	1.5	1.5	3.2	1.3	3.9	0.2	4.6	2.0	1.0	2.2	6.4	0.8	0.4	1.6	2.8	1.9	0.0	8.4	1.0	0.2	0.2	0.0	0.2	0.8	8.8	5.1	2.2	0.0	0.0	56.1	0.2	1.3	14.5	0.0	0.6	1.3	6.8	9.7	0.2	0.4	15.2	15.1	0.0	0.0	1.0	8.9	1.1	9.6	0.5	7.2	1.0	0.2	2.4	0.0	0.5	0.7	0.3	0.0	0.4	0.1	1.5	0.1	0.1	0.9	38.2	0.0	1.6	5.9	0.4	0.9	0.2	4.3	0.8	1.2	78.0	0.1	0.9
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047155-77076309	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	176.7	98.4	182.1	109.8	191.0	222.9	183.6	253.4	218.2	234.8	131.4	182.7	100.0	211.0	249.1	177.9	196.5	150.7	195.7	148.1	171.8	183.8	133.7	144.8	185.2	184.0	185.9	341.6	155.2	145.2	71.1	138.0	188.6	198.9	129.8	213.2	183.0	208.9	225.8	136.4	120.8	195.6	167.5	149.1	149.0	131.7	186.1	229.2	273.5	177.8	238.8	186.6	170.5	220.7	163.3	96.0	305.0	268.6	447.6	406.7	117.0	122.5	298.4	189.9	181.5	119.3	240.6	300.1	183.2	309.4	118.9	83.4	211.7	428.9	300.2	214.0	83.7	180.3	102.1	114.0	438.1	312.0	346.4	320.4	502.6	175.1	426.2	542.6	270.1	154.3	157.2	315.9	273.4	187.7	406.3	292.5	135.2	113.9	59.0	250.7	290.0	126.5	283.5	182.7	387.3	211.8	162.9	247.2	209.2	212.6	141.2	131.6	184.6	231.0	137.0	249.0	170.4	173.7	86.1	310.9	195.4	210.6	153.3	160.7	113.2	236.7	95.6	108.0	131.2	148.2	157.0	142.0	119.5	153.7	165.2	143.8	145.8	109.3	134.0	135.3	149.7	100.0	182.1	191.0	253.4	218.2	148.1	171.8	184.0	185.9	188.6	167.5	186.1	220.7	368.4	173.1	231.3	59.7	606.6	422.9	633.0	489.3	578.8	629.5	550.2	523.5	460.5	323.1	238.7	196.8	68.8	273.7	441.5	258.8	794.3	400.9	71.0	250.5	321.3	405.5	412.3	510.9	125.8	334.3	427.4	510.9	220.2	231.2	278.4	300.9	382.7	121.5	337.0	181.7	150.3	346.6	329.6	685.1	676.5	147.5	604.0	490.4	402.0	77.8	613.0	403.2	390.3	52.3	69.1	515.1	317.6	989.2	500.8	854.8	468.4	596.6	161.4	228.7	552.2	373.3	510.8	200.4	745.5	466.1	394.8	379.5	497.3	326.5	345.9	747.1
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CPXM1	"CPX-1, CPX1, CPXM"	ENSG00000088882	"Carboxypeptidase X, M14 family member 1"	Q96SM3	20	2794074-2800627	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 162.7;Fibroblasts: 60.1;Theca cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebral cortex: 6.9"	"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 161.7;HSkMC: 85.7;NB-4: 148.1;REH: 150.8;SH-SY5Y: 108.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 8.7"						"Secreted in other tissues"	NA	NA		490000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"				"unprognostic (7.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (4.62e-10)"	"unprognostic (1.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.27e-2)"	59.0	4.8	0.9	9.7	1.2	19.0	31.2	0.7	6.9	72.4	2.5	4.1	1.4	76.8	8.4	4.2	27.1	86.0	4.5	0.9	0.9	6.5	0.3	5.4	6.5	0.9	0.7	41.9	3.1	3.8	5.3	51.5	1.1	7.1	1.5	0.0	4.8	2.3	1.2	12.7	3.3	38.8	1.1	0.9	2.2	3.6	1.4	9.6	24.5	0.0	2.8	55.5	29.4	1.0	0.0	0.0	161.7	0.0	0.0	4.9	0.2	0.4	0.7	2.0	0.6	0.0	0.0	0.0	0.5	0.3	0.1	0.0	12.1	0.0	0.5	0.7	8.5	22.1	0.0	0.0	2.2	0.1	3.2	85.7	0.0	7.7	0.0	0.0	0.0	31.1	9.3	0.0	0.1	0.1	0.6	148.1	34.5	0.0	0.0	150.8	0.0	4.2	0.0	0.0	0.2	108.2	0.0	0.2	0.0	25.8	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.9	1.2	0.7	6.9	0.9	0.9	0.9	0.7	1.1	1.1	1.4	1.0	3.9	0.0	0.5	0.0	0.3	2.7	5.8	0.7	4.0	0.0	1.1	3.8	0.7	0.0	0.8	3.7	0.0	2.9	1.7	0.5	0.0	3.0	2.3	5.8	162.7	3.1	0.0	7.6	0.0	0.0	3.3	60.1	0.0	4.2	2.5	17.7	0.7	0.0	6.5	0.0	0.0	0.0	0.0	0.0	2.6	2.8	17.4	0.9	1.8	0.0	0.7	0.0	0.0	0.5	0.0	0.3	0.0	0.7	0.5	2.5	0.0	0.1	3.1	0.0	0.0	0.4	10.2	0.0	1.5	0.1	2.0	3.3	1.4	28.2	0.6	0.8
CXCL14	"BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14"	ENSG00000145824	"C-X-C motif chemokine ligand 14"	O95715	5	135570679-135579279	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 780.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 3435.4;Basal squamous epithelial cells: 3284.9;Breast myoepithelial cells: 1544.3;Fibroblasts: 2220.8;Glandular and luminal cells: 1201.1;Proximal tubular cells: 3662.8;Suprabasal keratinocytes: 2115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HAP1: 61.6;hTCEpi: 79.9;RPTEC TERT1: 222.2;SuSa: 115.2;U-2 OS: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB029996	Uncertain				"Secreted to blood"	NA	NA	800000		"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 33: Fibroblasts - ECM organization"			"CAB029996: AB_2086070"	"unprognostic (1.82e-3)"	"prognostic favorable (1.71e-4)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	366.1	5.2	77.6	76.2	84.5	0.6	229.1	70.6	102.7	166.3	74.8	152.4	214.0	6.9	66.6	92.9	32.9	19.8	14.0	83.7	73.8	345.6	58.5	7.4	90.7	72.4	91.0	5.5	11.6	1.9	122.0	170.7	72.4	10.1	181.3	17.5	293.5	17.6	81.1	780.3	247.0	6.3	68.7	87.5	107.3	3.7	90.2	26.6	55.2	36.5	128.5	76.6	96.3	77.9	0.0	0.0	2.7	0.0	0.2	0.2	0.7	2.9	0.8	0.2	0.0	0.0	9.1	0.0	2.7	0.1	3.8	0.2	61.6	1.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	79.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	4.0	0.0	0.0	0.2	0.0	1.1	222.2	0.0	1.1	0.7	0.2	0.2	0.0	115.2	0.1	0.0	0.0	0.1	84.9	0.4	0.1	0.3	0.0	0.0	1.4	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	77.6	84.5	70.6	102.7	83.7	73.8	72.4	91.0	72.4	68.7	90.2	77.9	123.8	0.0	1.1	32.7	13.1	3435.4	14.4	276.9	3284.9	245.7	47.5	1544.3	4.1	0.0	5.1	283.3	0.0	35.9	6.1	0.0	563.4	0.0	0.8	45.0	140.8	45.9	0.0	0.0	1.0	0.0	25.4	2220.8	0.5	1201.1	0.0	0.0	43.5	0.2	63.6	6.7	150.8	0.0	240.1	0.9	887.9	1.3	20.8	35.3	439.4	8.4	0.0	6.7	0.0	4.5	4.2	0.1	0.0	0.4	13.3	10.6	0.0	3662.8	2.1	19.0	0.0	889.8	99.2	0.4	5.2	69.3	2115.0	77.2	43.4	0.3	0.1	9.3
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 319.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.4;Cone photoreceptor cells: 89.6;Excitatory neurons: 176.1;Inhibitory neurons: 182.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 319.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 126.9;U-87 MG: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910"	Enhanced					NA	NA		8800		"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB005920: , HPA049910: AB_2680948"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	22.2	7.9	99.8	3.7	129.1	2.0	13.2	13.6	319.5	30.8	0.0	8.0	1.9	8.8	2.4	5.5	9.4	13.4	7.8	140.1	15.9	14.1	5.3	4.6	2.4	50.7	4.1	2.5	8.4	4.1	33.6	2.5	36.6	9.0	2.7	68.3	9.0	3.0	3.2	15.0	9.0	5.3	0.0	1.0	5.0	4.9	10.0	0.9	5.2	4.0	1.8	10.6	21.6	123.1	8.7	126.9	11.3	2.8	3.6	36.8	0.6	8.0	18.9	15.7	6.5	1.7	2.6	0.2	10.7	16.7	0.6	15.3	1.8	0.8	8.6	0.1	12.1	8.3	19.5	0.5	2.6	1.1	5.6	9.8	0.2	12.4	0.2	15.2	0.0	7.3	3.1	0.5	0.0	3.6	0.7	2.7	12.2	2.2	23.1	15.6	0.4	3.9	2.4	0.0	16.1	27.1	27.1	0.8	1.2	1.4	0.3	11.2	0.6	0.5	34.8	36.2	16.6	1.0	0.4	0.8	46.8	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.8	129.1	13.6	319.5	140.1	15.9	50.7	4.1	36.6	0.0	10.0	123.1	2.2	0.0	0.0	18.9	0.9	7.9	1.7	0.3	8.0	112.4	2.9	3.9	2.0	5.7	0.8	0.0	89.6	0.3	0.2	0.4	1.9	0.8	0.9	1.3	19.0	1.8	0.0	0.0	176.1	0.9	0.4	24.3	2.6	1.4	1.3	2.8	0.7	0.6	10.6	50.5	182.2	0.9	0.0	0.6	10.5	1.0	2.8	9.2	3.6	22.5	1.3	10.7	0.0	33.7	14.3	0.6	5.0	1.5	0.7	0.8	2.5	5.3	1.1	78.4	0.0	2.1	3.8	1.0	1.8	2.5	7.5	0.8	1.6	2.1	1.6	0.8
DOK5	"C20orf180, dJ805C22.1"	ENSG00000101134	"Docking protein 5"	Q9P104	20	54475593-54651169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.0;tongue: 24.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 110.7;Distal tubular cells: 39.2;Excitatory neurons: 49.7;Horizontal cells: 38.7;Inhibitory neurons: 79.6;Muller glia cells: 63.9;Oligodendrocyte precursor cells: 58.3"	"Group enriched"	"Detected in many"	6	"glioma: 18.0;ovarian cancer: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;ASC diff: 13.1;ASC TERT1: 11.0;hTEC/SVTERT24-B: 13.7;U-138 MG: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054460, HPA065235"	Uncertain		Approved	"Focal adhesion sites"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"HPA054460: AB_2682495, HPA065235: AB_2685441"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (8.99e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.49e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.99e-2)"	2.9	1.9	14.6	1.7	14.2	0.0	1.9	13.4	15.6	1.1	13.0	1.4	0.3	1.7	0.3	1.7	12.2	9.8	18.4	15.4	16.9	5.2	2.3	1.0	0.6	15.9	14.7	0.9	1.2	0.2	1.1	1.8	18.6	0.9	0.7	11.7	1.4	0.8	46.0	0.5	0.7	2.8	13.9	0.3	0.8	1.7	15.3	0.4	5.1	24.3	0.4	4.7	0.9	13.3	0.0	0.0	32.9	0.0	13.1	11.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	5.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	4.3	0.0	13.7	0.0	0.6	1.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	3.6	7.0	0.0	8.6	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.0	51.3	3.2	1.4	0.0	0.0	0.0	0.1	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	14.2	13.4	15.6	15.4	16.9	15.9	14.7	18.6	13.9	15.3	13.3	4.8	0.0	0.0	110.7	0.3	0.3	2.3	0.0	0.0	12.3	6.7	6.2	7.3	12.8	0.0	11.0	6.2	0.3	0.1	0.0	39.2	17.7	2.3	0.4	1.5	3.3	0.0	0.0	49.7	1.2	0.6	14.4	0.0	10.6	0.0	28.6	17.5	0.0	29.0	38.7	79.6	0.0	0.0	0.6	2.5	4.5	2.5	0.6	0.0	9.4	14.5	63.9	0.0	58.3	2.1	2.2	0.0	1.2	0.1	2.0	0.0	0.2	0.0	8.1	0.0	2.8	5.3	3.7	1.5	0.0	0.4	0.8	0.2	1.6	0.0	0.9
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044305	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.5;placenta: 35.3;retina: 27.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 95.0;Cone photoreceptor cells: 29.2;Extravillous trophoblasts: 19.7;Sertoli cells: 19.7;Spermatocytes: 23.0"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 31.2;HBF TERT88: 29.0;Hep G2: 23.4;RH-30: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 33: Fibroblasts - ECM organization"				"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.2	0.9	8.6	1.5	10.7	0.0	4.8	10.0	13.9	0.2	4.0	0.5	0.2	0.5	2.3	0.4	0.2	0.6	3.2	9.0	8.8	0.2	52.5	0.2	0.5	10.6	9.3	0.2	2.6	9.7	2.9	35.3	9.8	5.3	0.1	27.9	0.7	0.4	1.0	0.2	0.3	0.7	9.6	0.0	0.1	11.5	8.8	1.1	1.8	0.9	0.9	2.0	0.1	14.1	0.0	5.3	20.1	0.0	0.0	0.0	11.5	0.4	1.0	17.7	29.9	0.0	0.0	0.0	0.0	1.1	31.2	0.0	21.3	0.0	29.0	0.0	18.2	0.1	0.4	23.4	0.9	0.4	4.8	0.2	0.0	13.7	0.0	1.0	0.0	0.9	1.2	0.0	0.4	0.1	12.1	0.2	3.8	0.0	17.4	16.6	31.8	0.0	0.0	0.3	8.0	9.1	0.0	0.0	7.5	16.1	3.7	9.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	10.7	10.0	13.9	9.0	8.8	10.6	9.3	9.8	9.6	8.8	14.1	0.5	0.0	0.0	95.0	0.1	0.1	0.0	0.0	0.0	2.2	7.8	1.3	1.2	8.6	0.0	0.0	29.2	2.3	0.0	0.0	0.0	7.2	10.1	0.0	0.5	1.9	0.0	0.0	2.5	1.0	19.7	8.0	0.0	0.0	0.0	0.3	0.0	17.5	1.2	0.0	5.9	0.0	0.0	0.0	0.0	14.9	0.9	0.1	0.0	6.5	0.0	4.9	0.0	4.5	16.8	1.0	0.0	0.4	0.0	1.9	0.0	0.1	0.0	11.8	19.7	0.1	3.9	23.0	8.9	0.2	0.0	1.6	0.1	0.0	0.0	0.1
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 359.4;parathyroid gland: 98.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 141.9;Early spermatids: 202.2;Excitatory neurons: 77.6;Horizontal cells: 232.2;Inhibitory neurons: 105.1"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 12.2;OE19: 16.7;SH-SY5Y: 6.7;U-87 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	4.7	41.6	180.7	4.9	189.0	0.0	1.8	107.7	359.4	6.7	0.0	8.5	2.2	9.9	8.0	4.2	14.2	10.2	41.9	205.6	161.0	2.1	0.4	2.2	3.7	223.0	129.4	3.9	2.4	98.1	42.0	0.2	206.5	14.2	3.5	72.3	2.6	9.0	1.2	0.9	6.3	12.2	106.8	1.9	4.2	30.5	175.3	1.9	1.8	1.2	2.8	9.5	10.5	223.0	0.0	0.5	0.5	0.7	2.7	1.7	0.1	0.7	3.6	0.7	0.4	0.4	0.0	0.0	0.1	5.1	0.2	0.3	1.5	0.0	0.4	0.0	0.0	2.9	0.0	0.0	12.2	0.1	0.1	1.1	0.2	2.7	0.0	0.0	0.0	0.3	1.6	0.4	0.7	0.0	0.1	0.0	0.1	16.7	0.0	0.0	0.2	0.0	0.0	0.0	4.4	6.7	0.0	0.2	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.1	0.1	0.4	0.0	0.0	38.5	0.0	0.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.1	180.7	189.0	107.7	359.4	205.6	161.0	223.0	129.4	206.5	106.8	175.3	223.0	0.2	0.0	0.0	31.0	0.0	0.3	0.3	0.7	0.6	141.9	2.3	2.3	1.1	0.0	0.4	0.0	2.1	0.0	0.3	0.1	0.0	0.1	202.2	0.1	0.5	0.7	0.0	0.0	77.6	0.2	0.1	16.7	1.1	0.0	26.1	0.0	0.0	0.0	0.4	232.2	105.1	2.2	12.2	0.0	0.4	52.0	5.0	0.5	0.0	13.1	0.0	35.6	0.0	45.2	55.5	0.1	0.0	5.3	0.3	0.5	0.0	0.4	0.0	20.2	0.0	0.9	0.7	4.8	5.8	0.5	0.3	0.1	0.5	0.4	0.7	0.3
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552573-20555020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 21.0;brain: 21.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Distal tubular cells: 3.9;Excitatory neurons: 2.6;Fibroblasts: 3.8;Inhibitory neurons: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;BJ hTERT+: 2.4;fHDF/TERT166: 4.9;Hep G2: 3.7;SCLC-21H: 4.3;SiHa: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050813	Approved		Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA050813: AB_2681244"	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	1.6	21.0	12.2	0.2	10.7	0.0	0.3	11.0	12.5	0.6	2.4	0.9	0.1	1.0	3.0	0.3	0.9	0.2	3.9	13.5	13.5	5.0	0.4	0.3	0.0	16.6	21.7	0.3	0.5	0.0	0.8	0.6	13.8	0.7	0.1	0.4	0.5	0.1	0.9	0.2	0.3	0.8	9.9	0.8	0.3	0.5	18.8	0.1	1.2	1.4	0.0	0.7	0.4	10.2	0.0	1.7	0.2	3.3	0.1	0.1	0.0	0.3	2.4	0.4	0.0	0.1	0.0	0.0	0.2	4.9	0.8	0.0	0.5	0.0	0.0	0.0	0.7	0.1	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	10.7	11.0	12.5	13.5	13.5	16.6	21.7	13.8	9.9	18.8	10.2	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.1	1.9	1.6	0.0	0.0	2.6	0.0	0.1	3.8	0.0	0.2	0.0	0.0	1.8	0.0	0.1	0.0	7.5	0.0	0.0	0.6	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.3	0.1	0.9	0.7	0.0	0.0	0.1	0.1	0.1	0.0
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408313-48645721	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.9;placenta: 76.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		520000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	60.9	4.4	1.4	14.5	5.4	3.4	13.7	2.8	2.8	36.0	9.5	8.3	3.8	15.2	6.3	12.6	12.2	27.3	23.5	0.8	2.0	2.7	2.9	10.0	3.7	5.2	6.0	28.4	3.3	3.0	2.5	76.7	3.7	8.0	11.7	1.3	4.6	13.2	4.5	5.7	6.6	35.7	2.3	6.4	6.0	7.1	4.7	2.9	18.6	21.2	3.5	18.8	9.9	5.0	0.1	5.2	19.8	22.4	215.1	460.7	0.2	175.8	62.9	51.1	32.4	0.1	0.3	0.1	7.9	420.8	0.4	0.7	3.9	0.6	45.9	20.7	1.2	2.0	88.5	0.2	120.7	0.8	0.3	251.3	0.1	135.9	15.6	211.1	55.5	1.6	0.0	0.4	55.6	0.0	1.5	0.2	4.0	0.2	7.1	0.1	17.0	0.2	5.9	0.5	0.2	12.9	0.0	2.2	0.1	15.3	0.2	1.4	106.8	206.9	6.2	305.8	37.6	1.2	1.0	0.0	138.9	0.3	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	5.4	2.8	2.8	0.8	2.0	5.2	6.0	3.7	2.3	4.7	5.0	50.0	0.0	1.3	34.9	0.4	25.6	0.8	1.5	0.6	6.1	1.3	3.4	14.2	0.0	5.8	12.9	0.0	132.4	0.4	0.0	0.0	0.2	8.7	4.2	105.2	36.1	0.0	5.5	82.3	0.6	40.8	388.5	3.1	2.0	1.3	22.5	34.6	0.6	15.3	0.0	123.5	0.0	0.0	0.8	39.0	22.8	236.1	5.7	42.7	30.0	2.3	0.8	0.0	76.9	218.7	1.7	0.0	227.2	1.7	0.7	0.1	0.6	3.3	0.2	26.3	139.5	55.8	3.3	3.4	0.8	20.6	65.8	4.3	51.3	0.0	0.2
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 82.5;lung: 65.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Hepatocytes: 31.2;Skeletal myocytes: 141.2;Theca cells: 36.7;Undifferentiated cells: 38.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 42.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CACO-2: 173.9;Hep G2: 176.4;RH-30: 274.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		7400000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	1.2	14.0	1.1	4.1	1.1	0.5	4.5	2.7	2.1	3.0	1.2	18.0	21.3	2.4	0.2	3.2	4.2	10.2	2.2	1.4	1.0	40.2	82.5	65.4	0.8	0.7	0.8	27.5	29.5	0.2	2.0	2.1	0.9	5.2	6.0	1.5	1.1	0.7	6.6	1.7	20.0	1.1	0.7	22.7	8.8	5.9	1.1	0.2	0.9	1.9	0.2	6.4	3.2	1.3	3.2	48.8	1.0	11.7	0.1	0.1	24.5	0.2	0.1	0.2	0.3	173.9	6.5	5.3	23.0	0.1	2.4	2.8	9.5	1.8	0.1	3.2	13.8	0.5	2.8	176.4	5.2	0.6	4.7	1.1	0.2	8.4	0.2	0.3	0.2	3.5	18.1	0.7	3.9	40.3	0.1	3.6	29.2	30.9	4.5	8.2	274.3	30.9	22.9	0.4	1.8	2.9	1.8	12.4	5.9	5.9	11.7	2.5	1.1	0.0	23.4	0.3	0.7	1.6	1.9	3.7	0.1	1.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.1	1.1	2.7	2.1	1.4	1.0	0.7	0.8	0.9	0.7	1.1	1.3	0.3	0.0	0.0	0.3	0.3	0.6	0.7	0.4	0.0	0.9	2.9	2.0	0.9	78.6	0.1	3.7	0.0	1.3	0.1	12.9	3.9	10.9	0.1	1.6	0.3	0.7	4.2	0.0	0.5	4.9	3.8	9.6	9.7	2.9	0.0	0.7	3.9	31.2	0.3	0.0	0.5	10.1	0.0	0.9	0.5	0.0	0.6	0.7	0.0	1.9	0.6	0.6	0.0	0.5	0.1	3.0	4.4	1.5	0.1	1.7	15.9	21.6	0.1	0.4	19.7	141.2	0.7	3.0	9.9	0.8	0.4	8.8	0.4	36.7	38.6	0.5
FLRT2		ENSG00000185070	"Fibronectin leucine rich transmembrane protein 2"	O43155	14	85530144-85654428	"Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 29.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 279.5;Excitatory neurons: 549.6;Inhibitory neurons: 321.3;Leydig cells: 219.0;Microglial cells: 432.8;Oligodendrocyte precursor cells: 212.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basal ganglia: 2.1;cerebral cortex: 8.2;hippocampal formation: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.1;HUVEC TERT2: 38.7;TIME: 55.3;U-138 MG: 58.8;U-2197: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		17000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.59e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.34e-2)"	"unprognostic (8.02e-6)"	"unprognostic (1.98e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.50e-5)"	9.2	4.5	0.8	4.5	2.1	0.1	2.9	0.0	8.2	11.0	2.3	2.7	0.9	6.1	3.0	3.5	6.4	9.1	3.8	4.7	0.0	1.4	1.2	2.3	3.5	0.0	0.0	29.6	21.7	1.3	1.9	1.2	0.0	5.1	3.1	3.1	1.9	3.3	7.3	6.1	1.7	5.2	0.0	3.0	2.2	4.6	0.2	1.2	4.9	3.1	2.6	5.3	4.2	0.0	0.0	0.2	8.9	0.0	7.9	14.5	0.0	9.7	6.3	9.0	8.4	0.0	0.0	0.0	0.0	28.5	0.9	2.0	13.6	18.6	21.8	0.0	7.8	0.0	5.3	0.0	25.2	2.1	0.0	8.0	10.6	7.5	60.1	2.7	38.7	0.0	0.0	0.0	21.8	0.0	0.0	0.0	4.2	0.0	0.2	0.0	10.8	0.0	0.0	0.0	2.1	0.0	2.3	0.0	3.2	11.8	0.0	0.1	55.3	58.8	9.9	43.0	17.8	0.0	0.0	0.0	18.5	0.0	5.8	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	2.1	0.0	8.2	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.9	0.0	1.3	279.5	0.1	21.4	1.7	5.2	6.2	7.0	3.9	4.4	4.0	10.0	0.4	1.8	0.0	0.4	0.1	0.1	0.0	66.2	3.1	2.2	65.1	15.9	0.0	0.0	549.6	42.8	0.2	34.3	0.5	1.6	0.0	39.9	66.0	0.2	2.4	10.1	321.3	0.0	0.0	1.3	6.6	7.7	219.0	1.2	1.8	432.8	0.6	13.2	0.0	212.1	9.0	20.4	0.0	124.8	0.0	1.1	0.0	0.2	1.7	1.4	13.1	3.2	8.5	1.1	0.6	1.0	24.0	0.8	0.8	32.3	0.0	0.2
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910606-10198606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.6;Fibroblasts: 79.6;Inhibitory neurons: 76.6;Late spermatids: 73.4;Oligodendrocytes: 163.3"	"Group enriched"	"Detected in all"	4	"glioma: 15.7;melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 26.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 17.1;monocytes: 26.2"	"Cell line enriched"	"Detected in many"	9	"WM-115: 533.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"	27.3	8.5	34.9	23.7	68.9	31.1	15.3	75.4	79.8	29.9	0.0	26.3	7.3	13.3	4.3	23.8	17.8	16.3	46.1	61.9	8.4	1.7	2.3	17.1	9.1	23.4	24.1	7.8	3.4	1.1	2.6	16.2	15.8	8.5	12.0	30.1	7.8	10.8	5.8	33.7	11.9	24.0	14.3	16.1	8.9	17.4	32.9	9.3	4.6	6.8	10.3	18.3	19.5	85.3	0.1	0.5	0.6	1.0	16.5	22.5	0.3	0.8	0.0	2.6	1.1	0.1	0.2	6.6	1.9	6.6	0.3	0.3	0.0	0.0	1.6	0.0	1.5	0.0	1.3	0.7	5.3	1.8	48.7	4.3	0.3	5.1	0.1	0.0	0.0	42.7	0.0	0.6	0.0	0.0	54.3	15.4	2.6	2.1	0.0	14.3	0.1	49.6	0.0	0.2	0.1	3.0	0.2	0.2	60.1	21.0	2.8	24.7	0.0	0.2	3.4	0.1	0.1	0.4	0.0	0.0	0.4	35.1	533.8	0.6	26.2	17.1	2.8	6.9	0.9	0.5	0.3	1.4	5.3	0.6	0.2	1.4	16.4	4.5	4.9	1.0	0.0	7.7	34.9	68.9	75.4	79.8	61.9	8.4	23.4	24.1	15.8	14.3	32.9	85.3	2.9	0.0	4.2	6.8	3.3	8.3	4.5	1.5	1.2	34.6	1.6	2.3	13.3	0.0	1.1	5.5	27.1	1.0	14.5	0.0	0.0	1.0	62.3	17.7	12.8	5.7	0.0	0.4	133.6	0.0	1.8	79.6	0.0	26.3	17.2	7.9	5.0	0.9	39.2	0.0	76.6	0.0	0.0	66.7	32.2	73.4	10.2	54.3	33.8	52.5	57.2	9.5	18.6	11.1	163.3	0.2	0.0	1.9	5.5	2.0	0.0	0.1	16.3	31.7	0.0	67.0	7.1	1.6	6.7	1.0	16.6	1.9	7.4	0.2	0.0	4.9
GASK1A	"C3orf41, DKFZP434B172, FAM198A"	ENSG00000144649	"Golgi associated kinase 1A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.4;Extravillous trophoblasts: 2.6;Fibroblasts: 1.8;Hofbauer cells: 3.9;Syncytiotrophoblasts: 2.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;RPMI-8226: 3.4;SK-BR-3: 2.6;T-47d: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"	NA	NA		600000		"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	5.5	2.1	4.9	2.5	6.4	0.0	4.2	6.3	3.8	10.6	4.9	3.4	0.7	9.8	2.2	1.8	11.3	5.3	1.7	4.1	5.9	1.0	13.1	3.1	0.7	8.8	7.7	6.8	2.0	0.1	3.0	2.0	7.6	2.6	1.0	3.9	2.6	2.2	1.4	1.7	2.1	6.0	6.3	0.9	3.4	2.9	10.0	0.6	2.1	0.8	0.3	3.2	3.9	5.2	0.0	0.0	0.0	3.1	0.1	0.0	1.1	0.2	0.3	0.0	0.0	0.1	0.9	0.0	1.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.6	0.4	1.2	0.8	0.0	0.4	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	3.4	0.0	0.5	0.1	0.3	0.0	2.6	0.0	0.1	6.7	0.9	0.0	0.4	0.6	1.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	6.4	6.3	3.8	4.1	5.9	8.8	7.7	7.6	6.3	10.0	5.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142333-96160806	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease variant, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 10.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Distal tubular cells: 1.9;Excitatory neurons: 1.6;Fibroblasts: 3.1;Oligodendrocyte precursor cells: 7.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8;thyroid cancer: 2.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 20.4;LHCN-M2: 33.1;SuSa: 15.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.2"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	1.3	0.1	0.3	0.9	0.3	0.0	0.4	0.4	0.8	0.2	0.0	0.7	0.3	1.4	0.4	0.4	0.5	2.4	2.8	0.3	0.4	0.2	0.4	0.2	0.1	0.8	0.4	0.1	0.7	0.1	0.1	10.9	1.0	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.9	1.1	0.4	0.0	0.6	0.6	0.8	0.1	0.6	0.0	0.0	0.8	0.9	0.4	0.0	0.0	0.2	0.0	1.1	0.6	3.9	2.6	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	3.2	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	3.0	0.0	20.4	0.2	0.0	0.0	0.0	33.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.4	0.8	0.3	0.4	0.8	0.4	1.0	0.4	0.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.8	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1
GLP2R		ENSG00000065325	"Glucagon like peptide 2 receptor"	O95838	17	9822206-9892099	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 12.2;intestine: 13.5;urinary bladder: 11.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Excitatory neurons: 6.4;Leydig cells: 3.1;Rod photoreceptor cells: 23.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.1"	"Group enriched"	"Detected in many"	6	"basal ganglia: 3.0;cerebral cortex: 3.6;hippocampal formation: 3.2;white matter: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 78.1"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.1;hippocampal formation: 2.4"	"Low region specificity"	"Detected in all"			"CAB022690, HPA049244"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"CAB022690: , HPA049244: AB_2680690"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.63e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.40e-8)"	"unprognostic (9.53e-5)"	"unprognostic (5.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.48e-3)"	8.1	0.3	0.4	0.7	3.0	0.0	0.8	0.0	3.6	6.0	0.0	13.5	9.9	1.2	0.0	0.7	1.6	12.2	0.6	3.2	0.0	0.3	2.7	1.0	0.6	0.0	0.2	0.4	1.6	0.0	0.0	1.1	0.0	0.1	6.0	3.4	0.0	0.1	0.1	0.1	8.2	1.9	0.0	0.1	3.7	0.4	0.0	0.1	0.2	0.2	0.2	11.8	1.5	1.7	0.0	16.6	0.0	0.0	0.8	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	78.1	0.6	1.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	3.6	3.2	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	6.4	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.5	0.0	1.5	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	23.3	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXC4	"HOX3, HOX3E"	ENSG00000198353	"Homeobox C4"	P09017	12	54016931-54056030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 9.1;Endometrial ciliated cells: 12.3;Granulosa cells: 10.5;Sertoli cells: 6.6;Squamous epithelial cells: 8.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.4"	"Region enhanced"	"Detected in many"		"medulla oblongata: 16.7;pons: 16.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.8;HDLM-2: 31.2;HEK 293: 33.0;SH-SY5Y: 27.3"	"Region enriched"	"Detected in single"	24	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	49	"medulla oblongata: 4.9;pons: 3.7;spinal cord: 6.0"	HPA053910			Supported	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA053910: AB_2682305"	"unprognostic (2.78e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.96e-6)"	"unprognostic (3.30e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.37e-2)"	"unprognostic (7.81e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-4)"	"unprognostic (9.82e-2)"	8.6	4.5	0.1	2.1	0.1	0.1	5.2	0.1	0.2	1.0	0.1	2.1	1.1	4.7	7.2	8.1	27.0	0.4	0.5	0.2	0.2	13.5	0.1	0.8	3.6	16.7	1.1	11.1	0.3	0.1	0.1	6.3	16.2	1.6	0.2	0.0	0.3	0.9	9.1	6.2	6.8	4.8	6.4	1.8	5.2	3.3	0.3	0.4	1.0	0.0	1.9	0.7	0.8	3.7	5.3	5.1	0.0	23.8	9.4	4.9	0.0	2.4	2.5	2.4	1.7	0.2	4.3	20.5	0.2	18.5	0.1	4.7	0.4	0.6	1.5	31.2	33.0	0.2	2.9	0.0	1.1	2.5	0.7	12.5	2.3	13.7	2.4	0.0	0.3	6.7	1.1	0.0	8.9	0.3	2.8	0.5	0.1	0.9	0.1	6.7	7.2	0.0	10.2	0.0	0.0	27.3	3.8	1.2	13.7	1.1	18.0	1.2	0.0	12.0	6.9	1.0	12.8	5.3	6.0	10.6	0.7	2.3	12.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.2	16.7	1.1	16.2	6.4	0.3	3.7	1.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	9.1	0.0	1.4	3.4	0.5	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.9	0.0	4.1	12.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.6	0.1	0.0	10.5	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.0	2.9	3.1	0.2	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.1	0.0	1.5	3.7	0.0	0.1	2.9	0.0	0.0	6.6	3.9	3.6	2.7	0.5	8.2	0.0	0.3	1.6	2.7	0.1	0.0
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.1;ovary: 26.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 17.6;Fibroblasts: 14.0;Granulosa cells: 13.2;Leydig cells: 22.4;Peritubular cells: 15.1;Skeletal myocytes: 13.5;Spermatocytes: 34.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"medulla oblongata: 4.1;pons: 4.3;spinal cord: 3.1;white matter: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 94.4;fHDF/TERT166: 47.9;HDLM-2: 80.6"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	32	"spinal cord: 9.7"	HPA054981			Supported	Nucleoplasm,Cytosol		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	18.9	14.8	0.0	1.1	0.0	0.0	13.4	0.0	0.1	1.1	0.0	1.0	0.3	5.3	19.3	2.9	27.1	0.1	0.6	0.0	0.1	17.8	0.0	0.7	4.3	4.1	0.2	26.2	0.4	0.3	0.0	5.7	4.3	1.3	0.2	0.5	0.2	0.5	17.3	13.3	11.4	8.8	3.1	0.2	0.7	3.5	0.1	0.1	1.0	0.0	0.0	1.3	1.5	1.5	6.6	4.5	0.0	94.4	34.1	32.0	1.0	4.9	4.7	7.9	7.1	4.1	7.4	3.0	6.3	47.9	2.3	10.7	3.8	0.5	6.7	80.6	27.3	5.2	14.6	0.0	3.8	0.5	12.0	30.7	5.0	15.7	5.6	0.0	0.3	0.3	3.5	0.0	27.4	1.5	0.0	3.3	0.0	0.8	4.1	0.0	3.6	0.0	24.1	0.2	0.0	11.8	7.3	7.0	21.7	8.2	16.6	1.3	0.0	9.7	21.1	10.7	7.0	0.7	0.9	0.2	3.7	0.8	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.2	4.3	3.1	0.1	1.5	3.9	0.0	0.0	0.0	0.3	6.2	0.0	0.0	9.1	0.0	3.2	5.8	0.6	0.0	0.0	3.7	0.0	0.4	0.2	0.0	17.6	0.0	1.6	0.0	0.6	1.1	0.0	0.0	0.0	0.0	3.0	14.0	0.0	0.0	0.0	13.2	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	1.8	1.0	22.4	0.4	12.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.8	9.6	0.0	2.1	6.6	13.5	11.8	34.0	2.7	5.1	4.0	0.3	0.4	7.4	0.2	0.0
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122458551-122514907	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	246.0	81.3	382.1	37.0	436.6	0.5	202.8	422.6	595.7	352.1	316.2	154.8	20.8	197.1	247.1	57.8	122.9	301.2	114.7	377.7	411.4	230.9	226.4	69.9	39.9	427.1	447.0	425.5	55.9	111.8	184.1	281.9	425.3	85.7	51.8	243.6	101.1	114.5	31.1	130.5	73.5	152.3	382.1	54.2	87.3	19.5	423.6	21.2	78.8	80.9	27.3	137.3	188.3	464.2	0.3	45.6	19.4	5.7	2417.8	889.4	0.8	108.3	196.8	44.4	23.6	0.2	0.6	0.0	29.0	862.3	68.6	12.8	7.6	124.4	6.2	0.1	4.9	0.1	65.4	0.3	123.7	0.1	0.9	1581.4	444.6	25.8	205.3	503.6	207.1	0.0	0.1	1.5	1238.2	22.3	0.1	0.7	20.9	0.2	67.6	0.2	1.3	0.4	282.6	2.2	1.2	3.9	272.1	0.2	122.2	91.4	8.6	0.2	136.0	309.9	4.5	141.3	94.1	0.2	0.1	0.3	1004.6	0.2	148.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	382.1	436.6	422.6	595.7	377.7	411.4	427.1	447.0	425.3	382.1	423.6	464.2	55.1	22.4	6.9	116.5	0.9	44.1	32.5	10.8	23.9	53.3	5.4	31.2	26.4	14.3	0.9	64.4	54.2	30.9	1.3	0.0	0.0	2.0	3.5	11.3	76.5	107.0	0.0	2.7	2.2	4.6	164.6	269.3	4.6	14.4	1.3	731.6	57.8	157.8	51.3	625.9	31.2	0.3	8.2	18.1	59.9	4.2	31.7	22.0	46.2	86.2	8.5	373.8	0.0	193.0	112.5	2.7	1.3	77.5	1.9	8.7	0.2	22.6	10.1	150.3	6.6	63.3	140.5	0.2	0.7	7.0	30.5	87.7	7.2	2.5	0.6	11.9
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 580.8;Fibroblasts: 1360.5;Leydig cells: 1030.8;Peritubular cells: 1495.9;Sertoli cells: 1170.1;Smooth muscle cells: 420.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 145.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 31.6;non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1163.6;BJ: 476.9;BJ hTERT+: 683.3;fHDF/TERT166: 1045.9;hTERT-RPE1: 468.5;U-87 MG: 631.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 120.2"	"HPA008005, HPA075088"	Uncertain				"Secreted to blood"	NA	NA	199000000	300000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA008005: AB_1851499, HPA075088: "	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	145.8	90.2	28.1	9.2	32.6	0.4	150.5	31.8	40.8	276.6	71.6	75.5	20.8	117.2	129.5	75.8	237.4	36.8	107.0	28.4	33.1	30.6	7.7	40.4	8.7	32.7	29.2	136.8	15.9	4.8	106.3	15.7	33.2	129.3	28.0	6.6	35.9	122.2	38.5	39.2	52.5	39.0	36.7	45.2	67.6	22.2	41.7	6.8	58.4	102.2	9.2	127.1	214.1	27.2	135.3	219.6	0.2	177.3	313.9	1163.6	0.8	476.9	683.3	126.9	69.0	23.2	294.7	0.0	68.5	1045.9	96.4	453.3	3.0	42.3	26.2	1.2	2.8	4.4	37.1	33.3	111.9	0.8	1.1	325.5	2.3	57.4	11.9	468.5	30.5	7.5	0.6	9.3	53.1	0.5	6.6	1.0	6.8	4.1	150.4	2.3	4.9	5.6	10.1	3.3	1.3	8.7	152.2	0.0	10.9	4.0	6.3	0.5	132.2	87.2	41.2	95.5	18.0	5.3	10.7	0.6	631.6	6.7	49.5	0.0	0.0	31.6	0.6	6.8	3.4	0.1	1.0	5.4	2.1	0.0	0.5	6.8	0.0	0.0	20.1	0.0	0.0	1.5	28.1	32.6	31.8	40.8	28.4	33.1	32.7	29.2	33.2	36.7	41.7	27.2	83.9	6.4	4.2	2.0	3.4	113.6	41.0	580.8	23.9	2.5	5.9	29.0	21.1	10.0	37.6	20.2	0.0	3.0	3.5	0.2	11.7	87.9	9.6	4.9	99.2	71.9	0.0	3.2	3.1	8.0	4.9	1360.5	30.5	2.5	0.0	2.3	116.4	0.8	7.6	0.0	3.6	0.3	50.8	6.8	122.8	32.6	1030.8	15.2	144.1	19.7	2.5	51.1	0.0	1.5	0.9	77.1	0.0	1495.9	9.6	94.9	0.0	15.2	13.9	2.8	1170.1	102.3	420.9	3.8	6.8	8.0	87.8	3.4	14.1	0.4	0.0	34.1
IGSF10	"CMF608, FLJ25972"	ENSG00000152580	"Immunoglobulin superfamily member 10"	Q6WRI0	3	151425384-151458709	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 170.5;Horizontal cells: 60.6;Late spermatids: 34.1;Microglial cells: 61.8;Syncytiotrophoblasts: 30.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 44.1;HL-60: 23.3;REH: 17.2;RPMI-8226: 55.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA012655, HPA012921"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		540000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA012655: , HPA012921: AB_1851526"	"unprognostic (1.78e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.47e-7)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.84e-4)"	"unprognostic (9.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.52e-4)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.57e-4)"	3.9	4.0	1.4	0.9	0.7	0.6	6.1	0.3	1.0	0.5	3.2	1.3	0.5	1.4	1.6	2.9	4.3	9.7	4.3	2.8	1.1	0.2	0.3	8.6	1.4	0.1	1.0	17.7	0.7	1.3	1.7	0.7	0.3	0.1	1.3	0.2	5.2	0.2	0.1	1.9	1.2	1.5	0.0	0.9	0.7	0.9	3.6	1.3	1.5	0.5	2.5	2.2	0.3	0.3	0.0	0.1	0.3	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.4	0.0	0.0	0.3	0.3	7.5	44.1	0.0	1.6	23.3	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.2	0.1	55.1	0.1	0.1	1.0	0.0	5.9	0.0	0.0	0.2	0.0	0.2	0.0	0.1	1.1	0.0	0.0	2.4	0.0	0.0	0.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.7	0.3	1.0	2.8	1.1	0.1	1.0	0.3	0.0	3.6	0.3	2.0	0.0	0.5	1.0	0.6	2.4	1.2	0.5	2.8	15.8	0.6	0.9	1.6	2.8	6.3	1.8	4.2	21.7	2.7	0.2	0.0	0.1	170.5	11.4	4.0	0.9	6.0	3.4	2.4	1.3	2.9	20.4	0.5	0.5	0.0	0.0	0.0	0.1	1.3	60.6	2.8	0.7	4.1	0.8	3.2	34.1	6.8	2.9	3.6	61.8	1.1	25.6	0.0	0.5	0.7	0.4	0.1	1.2	0.3	0.7	0.0	0.3	12.5	2.4	0.0	0.5	2.2	10.7	7.9	0.8	2.4	30.9	0.6	2.5	0.1	0.2
KIAA1755	RP5-1054A22.3	ENSG00000149633	KIAA1755	Q5JYT7	20	38210503-38260772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 105.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 63.3;Microglial cells: 67.5;Oligodendrocytes: 135.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 75.6;ASC diff: 11.3;ASC TERT1: 16.9;WM-115: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051064	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli	"Golgi apparatus, Vesicles"	"HPA051064: AB_2681331"	"unprognostic (3.98e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-8)"	"unprognostic (1.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.53e-3)"	5.6	2.1	18.4	6.0	87.7	0.5	3.4	39.2	42.2	13.1	0.0	9.0	2.4	14.6	6.4	5.1	8.7	16.2	11.4	29.0	64.1	4.1	1.2	2.5	5.0	59.2	62.3	13.6	0.9	0.1	2.2	0.1	54.7	6.6	4.2	0.5	5.8	7.3	0.6	1.4	4.2	14.7	18.3	2.7	3.6	2.6	75.3	8.3	2.0	1.7	4.7	5.2	4.8	105.0	3.0	0.3	75.6	0.1	11.3	16.9	0.0	7.6	4.3	0.0	0.0	0.3	2.2	0.0	0.3	2.4	2.5	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.3	0.0	2.2	1.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	2.0	0.1	0.0	0.0	0.4	0.0	1.1	0.4	1.4	0.0	0.0	0.0	0.2	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	87.7	39.2	42.2	29.0	64.1	59.2	62.3	54.7	18.3	75.3	105.0	0.1	0.0	0.0	63.3	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	2.5	0.2	0.0	0.0	0.8	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.4	1.1	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.9	3.7	0.2	1.8	67.5	0.0	0.0	0.0	19.6	135.6	0.6	0.0	7.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.1	1.2	0.3	0.3	0.2	0.3	0.0	0.0	0.4	0.0	0.0
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.0;breast: 26.1;heart muscle: 24.9"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	36.0	0.5	0.0	4.7	0.0	0.0	26.1	0.0	0.1	8.0	0.0	4.7	1.6	5.5	1.1	3.7	9.0	5.7	24.9	0.0	0.0	0.2	0.1	1.4	6.6	0.0	0.0	1.0	1.5	1.2	0.5	0.1	0.0	2.6	2.4	0.0	4.9	1.9	8.3	6.6	5.1	10.6	0.0	10.8	3.0	1.1	0.0	3.0	1.9	17.1	5.3	7.7	7.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MFAP5	"MAGP2, MP25"	ENSG00000197614	"Microfibril associated protein 5"	Q13361	12	8637346-8662888	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 242.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.5;Extravillous trophoblasts: 1015.1;Fibroblasts: 579.7;Syncytiotrophoblasts: 252.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 31.7"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 172.2;BJ: 63.7;EFO-21: 150.4;HeLa: 55.9;SuSa: 137.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"spinal cord: 42.6"	HPA010553	Enhanced				"Secreted to extracellular matrix"	NA	NA		3200000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA010553: AB_1853843"	"unprognostic (1.80e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.79e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.05e-1)"	"unprognostic (4.41e-7)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.81e-4)"	141.7	10.9	3.5	5.4	5.0	3.5	79.7	31.7	9.2	59.9	1.8	37.8	7.2	242.1	11.1	35.0	25.8	28.2	54.4	4.8	0.8	3.1	12.7	8.7	4.8	2.9	0.4	2.4	5.5	2.4	3.7	94.5	1.9	6.4	42.0	7.9	17.2	49.7	28.5	38.7	19.0	142.1	0.0	1.9	23.6	6.9	1.7	3.2	14.4	118.1	3.4	43.1	60.7	6.6	1.4	5.7	1.6	2.6	29.4	12.4	172.2	63.7	1.2	0.8	1.1	2.3	1.0	0.6	150.4	19.8	1.6	9.1	0.6	13.1	0.0	0.5	0.4	1.6	55.9	1.9	0.4	1.3	0.6	8.7	4.4	7.3	0.0	3.3	0.0	2.0	2.7	3.7	52.7	0.8	1.9	0.8	3.2	0.9	2.9	1.2	1.3	6.5	6.5	2.6	0.7	0.9	1.9	0.7	1.0	137.1	24.0	0.8	2.3	10.7	21.5	45.7	3.0	2.1	1.9	2.3	6.0	0.7	0.1	2.9	0.8	0.7	0.2	0.7	0.4	0.1	0.1	0.1	0.4	0.3	0.4	0.1	1.1	0.2	0.5	0.3	0.0	0.3	3.5	5.0	31.7	9.2	4.8	0.8	2.9	0.4	1.9	0.0	1.7	6.6	61.5	12.8	5.8	0.3	0.5	23.1	0.4	1.8	0.6	0.2	0.6	0.9	7.0	0.0	2.0	0.0	0.0	140.5	0.5	0.0	0.0	0.5	0.3	5.1	3.9	20.1	0.0	0.0	0.2	0.0	1015.1	579.7	3.6	28.0	0.0	0.2	4.2	0.0	27.7	0.0	0.1	0.0	0.0	9.5	36.3	0.5	61.2	8.8	12.4	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	1.6	0.1	0.0	0.2	1.6	0.9	0.0	40.2	35.2	0.1	0.2	0.6	18.0	252.3	5.3	0.1	0.0	0.3
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032011-88328025	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 2402.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.4;HUVEC TERT2: 12.8;SH-SY5Y: 16.2;U-138 MG: 13.7;WM-115: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	0.7	0.3	4.6	0.3	5.8	0.0	1.8	2.2	5.4	1.7	0.0	0.8	0.1	1.6	0.6	0.4	0.6	2.6	0.8	5.1	3.9	0.1	0.1	0.2	0.2	1.0	1.5	1.0	0.6	0.2	0.5	1.0	1.3	0.9	0.4	0.4	0.3	0.7	0.1	0.2	0.3	1.3	1.4	0.4	0.3	0.4	3.0	0.4	1.0	0.5	0.2	0.9	0.5	3.3	0.0	0.2	7.9	29.4	1.0	2.0	0.0	10.9	1.6	3.0	1.8	0.0	0.1	0.0	0.0	4.9	1.8	0.0	5.8	0.0	3.7	0.0	3.4	0.0	0.0	0.0	2.4	0.0	0.5	1.4	0.0	4.4	1.3	5.4	12.8	0.1	0.0	1.1	1.7	0.0	0.0	0.0	1.7	0.0	3.0	0.3	0.6	0.0	0.6	0.1	0.2	16.2	0.0	0.0	0.2	2.2	1.1	0.0	7.1	13.7	7.7	0.2	4.2	0.0	0.0	0.0	5.7	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	2.2	5.4	5.1	3.9	1.0	1.5	1.3	1.4	3.0	3.3	2.2	0.0	0.0	20.5	0.1	1.1	0.0	0.0	0.6	4.4	0.8	1.4	1.0	0.0	0.0	0.0	2.1	0.1	0.1	0.0	1.9	0.0	6.5	0.5	15.9	5.2	0.0	0.0	443.4	0.0	0.1	16.0	0.0	0.4	0.0	1.9	1.4	0.0	0.4	1.7	300.3	0.0	0.0	0.0	1.6	6.5	0.9	0.4	1.8	10.3	0.0	3.0	0.0	2402.1	13.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.7	2.9	0.0	1.1	0.2	0.1	0.0	0.2	3.4	0.0	0.1
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.3"	"Group enriched"	"Detected in many"	5	"Hepatic stellate cells: 60.3;Peritubular cells: 29.0"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HAP1: 14.2;HEK 293: 10.5;NTERA-2: 25.8;SH-SY5Y: 5.6;U-2 OS: 12.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	0.6	1.6	11.2	0.8	9.8	1.5	0.8	3.8	9.8	6.2	2.3	3.1	0.5	5.3	16.1	1.0	3.6	1.4	1.0	9.2	10.0	3.9	1.3	0.3	0.3	5.0	7.1	16.9	0.3	0.0	2.1	0.0	7.1	14.9	0.7	1.5	0.5	14.6	0.1	0.4	1.0	4.1	4.1	3.4	1.2	26.3	11.9	0.4	0.6	0.2	0.3	3.9	3.6	9.3	0.0	0.0	7.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.0	14.2	0.6	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	11.2	9.8	3.8	9.8	9.2	10.0	5.0	7.1	7.1	4.1	11.9	9.3	0.2	0.0	1.3	0.7	0.2	1.0	4.9	0.6	1.8	0.5	0.1	1.5	0.2	0.0	0.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.7	3.5	2.5	0.0	0.8	5.0	0.0	1.0	3.1	0.0	0.1	0.0	5.0	60.3	0.3	0.2	0.0	1.9	0.0	0.0	1.9	0.4	6.2	5.9	0.1	1.8	1.0	0.0	1.7	0.0	3.5	0.6	0.0	0.0	29.0	1.4	2.8	0.0	0.1	0.0	0.5	0.0	1.5	1.9	3.8	7.8	0.4	0.1	0.4	0.2	0.9	0.0	0.2
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219703-22232101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 14.8;Excitatory neurons: 48.5;Inhibitory neurons: 15.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3;thyroid cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.3;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 101.1;basal ganglia: 300.5;cerebellum: 251.7;cerebral cortex: 256.5;hippocampal formation: 296.8"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	11.3	33.1	106.0	1.5	183.9	0.0	9.3	98.1	217.1	11.6	0.0	14.1	1.3	14.5	2.8	9.8	25.6	6.7	5.2	210.3	21.9	9.4	0.7	2.5	0.2	63.7	11.5	7.1	1.6	0.2	35.7	2.5	58.1	11.9	0.6	2.2	1.8	5.9	0.9	55.8	5.1	8.1	2.0	11.5	3.7	10.7	30.7	0.2	3.9	0.3	0.2	12.1	15.1	137.4	0.6	1.6	0.3	0.0	0.2	0.5	0.8	0.2	0.9	0.2	0.2	0.1	1.4	0.0	1.5	0.5	1.0	2.6	0.0	0.4	0.0	0.0	0.1	0.0	3.0	1.0	1.1	0.0	0.0	0.6	0.0	0.6	0.0	2.5	1.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.2	9.3	0.0	0.0	2.9	3.5	2.0	0.0	2.4	0.2	0.0	0.2	0.7	0.0	1.4	1.1	0.5	0.6	0.1	0.0	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.0	183.9	98.1	217.1	210.3	21.9	63.7	11.5	58.1	2.0	30.7	137.4	1.1	0.0	0.0	7.2	0.0	18.9	5.5	5.6	14.8	1.5	0.7	1.3	1.4	1.5	1.9	3.7	0.0	0.1	0.1	0.2	0.0	0.2	0.8	0.4	3.6	1.5	0.0	0.0	48.5	2.1	0.4	5.6	0.5	0.2	0.0	0.0	1.4	1.0	0.2	0.0	15.4	0.7	0.0	0.0	1.4	1.8	3.1	0.1	1.8	5.6	0.0	0.6	0.0	7.5	5.8	0.8	0.0	3.8	0.0	1.3	2.6	3.5	0.3	1.1	0.0	0.2	8.0	0.4	0.4	8.2	10.9	2.2	0.2	0.1	0.1	5.0
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 1640.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 33.1;eosinophil: 29.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 220.8;BEWO: 186.8;HHSteC: 233.2;HSkMC: 302.2;U-87 MG: 326.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	210000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	437.9	188.9	107.9	80.5	109.8	20.7	122.6	100.8	142.0	155.4	197.6	76.9	41.6	114.9	72.6	62.0	173.5	182.3	123.4	100.4	119.0	198.9	29.5	97.1	61.3	119.5	152.2	159.5	296.9	22.1	38.5	428.8	126.0	50.7	42.4	4.8	132.1	71.5	24.0	68.0	71.6	181.9	124.7	57.6	89.7	32.3	114.5	229.9	44.4	20.8	21.1	339.7	113.1	118.1	13.8	1.9	94.9	0.1	220.8	66.8	186.8	5.3	16.3	18.5	11.0	78.7	15.9	3.5	151.6	23.6	0.4	154.7	29.2	0.6	8.4	1.8	0.2	28.8	3.3	37.7	233.2	0.0	35.5	302.2	7.7	49.1	0.9	74.1	41.3	3.2	9.5	44.9	6.2	3.9	3.2	123.1	16.9	12.5	74.5	1.3	0.1	1.7	0.5	0.0	10.1	35.4	3.7	110.3	160.9	15.7	1.5	117.2	9.0	46.2	1.1	24.2	0.8	19.7	5.3	5.4	326.4	34.3	7.8	33.1	2.7	29.7	1.6	7.1	1.2	8.7	0.4	1.6	2.5	3.2	0.0	1.0	1.4	4.9	12.6	17.5	0.8	2.7	107.9	109.8	100.8	142.0	100.4	119.0	119.5	152.2	126.0	124.7	114.5	118.1	21.9	0.0	2.3	30.3	3.8	40.7	34.9	53.0	33.0	0.4	9.5	22.6	1.5	5.7	9.6	27.6	0.0	14.8	3.5	0.5	1.9	3.4	16.3	54.6	36.9	27.9	0.0	9.0	0.8	103.2	97.7	256.8	3.6	5.7	0.0	23.4	121.1	2.8	1640.3	3.3	1.4	1.2	12.2	254.0	40.9	24.9	307.9	71.8	35.6	4.7	3.8	13.8	7.2	0.5	0.2	9.9	0.0	199.0	11.8	15.7	0.0	18.2	70.8	1.1	32.9	16.1	35.6	5.7	7.3	24.0	35.8	31.7	3.3	99.5	0.7	18.4
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568137	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 80.7;urinary bladder: 81.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 28.1;Fibroblasts: 70.8;Hepatic stellate cells: 117.8;Leydig cells: 26.8;Peritubular cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 45.1;ASC TERT1: 45.2;U-2197: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	43.2	4.7	0.7	9.0	2.5	0.3	24.0	0.3	1.9	29.5	1.8	38.9	3.2	79.0	16.1	16.5	80.7	31.3	40.4	0.5	0.8	4.0	6.0	18.2	0.7	0.6	0.4	38.1	2.5	0.3	0.9	1.1	0.4	22.2	6.6	0.2	7.6	8.3	4.0	7.2	10.5	40.5	0.6	0.5	17.9	5.1	1.0	0.3	7.8	2.4	0.8	81.7	18.2	0.6	0.0	0.1	1.9	0.1	45.1	45.2	0.5	1.0	5.7	0.2	0.0	0.0	0.0	0.1	18.4	13.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.1	3.3	0.0	0.6	0.0	15.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.2	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.2	0.0	8.2	0.1	0.0	0.0	0.8	2.4	143.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.7	2.5	0.3	1.9	0.5	0.8	0.6	0.4	0.4	0.6	1.0	0.6	5.3	3.2	2.7	0.0	0.0	3.7	0.7	0.0	0.0	1.1	2.2	1.3	5.0	2.8	1.9	3.7	0.0	0.3	0.3	0.0	0.0	0.6	1.8	0.0	0.9	28.1	0.0	2.7	2.7	0.0	0.2	70.8	1.5	0.1	0.0	25.0	117.8	1.0	0.3	0.0	2.4	0.0	0.0	3.1	6.7	3.3	26.8	1.0	1.8	6.5	0.1	0.4	0.0	1.0	0.2	1.2	0.0	104.9	0.3	0.4	0.0	0.2	2.2	4.5	0.0	7.9	3.5	0.7	1.4	0.5	4.8	0.3	1.0	0.5	0.0	0.6
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 41.4;Excitatory neurons: 66.8;Inhibitory neurons: 92.6;Microglial cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.7;HEK 293: 16.0;hTERT-RPE1: 82.3;WM-115: 36.5"	"Region enriched"	"Detected in all"	9	"basal ganglia: 109.2"					"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	4.1	7.0	3.5	2.6	15.0	0.0	6.9	2.2	6.6	9.3	7.2	6.0	1.7	7.4	6.7	7.9	6.0	5.3	14.0	3.5	1.4	15.1	6.5	5.3	6.7	3.4	1.7	11.5	1.3	6.0	7.5	14.4	0.9	12.5	2.2	13.6	13.1	11.2	2.4	1.1	2.0	5.9	1.4	4.9	3.9	0.6	2.4	1.2	9.1	5.3	4.2	7.2	6.1	3.7	0.0	1.9	1.2	6.4	13.7	3.6	0.0	1.6	0.8	0.0	0.6	0.3	0.1	0.1	0.2	2.5	0.3	0.4	0.0	0.3	0.0	0.1	16.0	0.1	0.1	1.1	0.3	0.2	0.1	7.1	0.0	0.0	0.0	82.3	13.4	0.1	0.1	5.6	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.6	8.3	0.0	0.2	0.1	9.1	0.0	0.1	0.0	1.1	0.1	2.1	7.0	0.2	0.0	0.1	5.6	0.2	36.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	15.0	2.2	6.6	3.5	1.4	3.4	1.7	0.9	1.4	2.4	3.7	2.4	0.0	0.5	41.4	0.3	0.1	18.0	6.4	1.8	4.5	1.7	7.5	12.0	12.8	14.9	11.0	25.0	0.2	0.8	0.0	0.0	1.6	1.5	8.3	4.2	10.5	0.0	0.0	66.8	0.9	0.1	6.8	7.7	3.0	0.0	0.1	22.1	2.1	0.4	5.0	92.6	0.0	2.0	1.9	0.4	1.2	0.0	0.3	0.0	29.0	0.0	24.8	0.0	19.6	2.9	1.4	0.0	0.0	0.2	10.2	0.6	0.6	9.2	6.3	0.0	2.9	9.7	0.2	1.0	6.6	0.1	0.3	0.5	0.2	0.2	9.7
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 221.9;fallopian tube: 206.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 217.1;Club cells: 621.4;Prostatic glandular cells: 312.9;Urothelial cells: 737.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 93.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	10	"CAPAN-2: 1319.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	221.9	21.3	1.0	65.1	1.5	0.6	44.6	1.5	1.7	74.6	11.3	31.7	5.1	25.9	27.0	11.3	206.4	19.7	81.5	1.5	0.8	25.1	4.2	52.7	18.9	0.6	0.4	60.5	10.0	0.2	27.7	3.5	0.4	78.6	36.2	0.9	165.3	37.2	5.6	8.3	38.5	51.2	0.4	2.7	23.7	4.5	1.0	1.8	20.4	2.8	6.2	92.1	32.2	1.4	19.2	6.9	0.2	1.0	4.0	12.6	0.3	1.8	5.7	1.0	1.4	1.4	1319.3	0.0	1.2	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.1	12.0	0.0	0.0	131.3	0.0	0.5	0.0	8.9	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.7	5.8	0.0	0.0	0.0	0.1	0.3	22.9	0.5	1.7	16.7	1.3	0.3	0.0	1.9	2.3	1.3	1.1	0.0	4.6	0.0	0.0	0.0	0.0	1.5	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	1.5	1.5	1.7	1.5	0.8	0.6	0.4	0.4	0.4	1.0	1.4	5.2	0.0	0.6	2.3	0.9	0.5	217.1	92.7	11.4	0.4	99.7	35.6	0.9	11.5	621.4	14.7	0.0	2.9	1.6	59.0	0.0	10.5	29.5	14.4	98.4	18.1	37.5	3.6	14.2	4.7	0.8	101.3	1.1	16.9	29.9	0.3	31.8	6.0	10.8	0.0	10.6	102.3	40.7	1.6	1.7	33.1	10.8	11.0	5.4	1.9	0.0	4.2	0.0	4.5	7.6	2.3	106.1	1.2	1.2	312.9	140.7	19.7	149.3	0.7	0.0	7.7	46.7	3.8	0.7	7.8	0.4	11.4	3.3	0.1	88.3	737.7
RSPO2	MGC35555	ENSG00000147655	"R-spondin 2"	Q6UXX9	8	107899316-108083642	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	"Developmental protein, Heparin-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;intestine: 13.9;placenta: 17.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 75.3;Inhibitory neurons: 86.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;U-266/70: 4.2"	"Group enriched"	"Detected in many"	7	"amygdala: 7.9;cerebral cortex: 17.9;hippocampal formation: 21.3;white matter: 13.2"	"Group enriched"	"Detected in many"	4	"amygdala: 8.3;cerebral cortex: 7.7;hippocampal formation: 8.5;midbrain: 12.9;spinal cord: 7.7"	"HPA024764, CAB025900, HPA053068"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031"	"unprognostic (1.10e-2)"		"unprognostic (2.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.33e-3)"		"unprognostic (1.82e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (1.40e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	0.2	0.0	2.8	0.7	4.4	0.1	0.0	1.3	16.2	3.4	2.6	13.9	3.4	0.0	1.7	5.9	0.0	3.2	0.2	6.6	13.2	0.0	0.4	7.1	0.0	2.6	23.0	0.3	0.0	0.0	2.9	17.3	2.0	8.7	7.8	0.3	0.0	2.3	0.0	0.0	4.6	0.3	2.1	0.0	7.6	0.7	3.5	0.0	0.0	0.0	0.0	1.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.4	1.3	16.2	6.6	13.2	2.6	23.0	2.0	2.1	3.5	6.6	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.3	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	86.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	4.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.0	1.7	0.0	0.0	1.0	0.0	0.2	0.0	0.0
RSPO3	"FLJ14440, THSD2"	ENSG00000146374	"R-spondin 3"	Q9BXY4	6	127118671-127199481	"Cancer-related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 51.4"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 18.5;Endothelial cells: 42.4;Fibroblasts: 73.0;Hepatic stellate cells: 26.4;Inhibitory neurons: 17.8;Leydig cells: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 21.9;BJ hTERT+: 3.6;hTERT-RPE1: 6.3;U-138 MG: 4.6;U-87 MG: 4.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 21.2"	HPA029957	Uncertain				"Secreted to blood"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA029957: AB_10602087"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.89e-3)"	30.9	15.1	2.1	16.1	2.4	0.0	12.4	3.3	4.9	13.8	0.0	7.4	2.2	51.4	28.4	5.4	25.3	11.1	0.9	8.5	1.5	4.0	6.5	5.1	3.7	1.6	1.4	3.6	1.6	0.1	3.1	35.4	0.3	6.3	6.6	0.1	5.4	20.0	39.8	2.8	10.3	48.1	0.0	1.8	13.3	1.0	1.0	2.4	3.6	5.0	1.4	8.6	7.1	0.9	0.0	21.9	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	6.3	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	4.6	1.8	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	3.3	4.9	8.5	1.5	1.6	1.4	0.3	0.0	1.0	0.9	3.6	0.0	0.0	0.7	0.1	0.9	0.1	0.0	0.6	1.5	0.2	0.9	0.5	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.4	12.3	0.3	18.5	42.4	0.0	0.0	5.9	0.0	1.1	73.0	5.1	0.3	0.0	0.0	26.4	0.4	1.6	0.0	17.8	0.0	0.0	1.0	0.8	2.2	27.4	0.4	1.8	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.2	6.6	2.1	3.5	0.1	0.4	0.4	0.1	1.6	0.1	0.1	0.0	0.2
SAMD11	MGC45873	ENSG00000187634	"Sterile alpha motif domain containing 11"	Q96NU1	1	923923-944575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 266.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 87.6;HeLa: 142.1;SCLC-21H: 71.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030110			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"HPA030110: "	"unprognostic (9.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.18e-1)"	3.8	9.0	3.6	3.3	4.5	1.0	1.8	6.0	8.8	7.4	7.2	4.9	5.1	9.6	9.4	1.9	17.6	3.2	13.2	5.6	9.0	19.7	4.3	3.9	2.1	23.4	10.5	3.3	1.4	1.6	27.6	0.3	10.9	16.9	1.1	24.5	2.0	19.5	0.8	0.8	5.4	4.1	8.8	17.1	4.9	4.7	8.3	0.1	4.7	0.3	0.4	14.0	7.9	10.1	0.3	8.0	0.1	7.4	0.4	0.1	2.0	9.2	0.5	0.6	0.3	0.4	2.4	0.0	19.0	26.0	5.1	15.3	8.8	0.0	0.0	0.8	87.6	0.0	142.1	0.4	1.9	0.0	0.9	5.3	0.0	0.1	0.0	12.1	0.0	0.2	3.5	0.0	0.2	8.4	0.0	0.1	3.8	0.5	0.8	0.7	1.4	5.6	1.2	0.0	71.1	20.9	23.8	12.3	0.2	6.1	12.8	0.5	1.4	3.8	14.4	0.2	2.6	1.3	0.0	0.3	5.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	3.6	4.5	6.0	8.8	5.6	9.0	23.4	10.5	10.9	8.8	8.3	10.1	0.1	0.0	1.8	12.1	0.3	0.4	0.1	0.3	0.6	25.5	0.7	0.4	0.9	2.8	1.9	3.7	29.2	0.2	0.1	0.2	0.0	1.0	3.9	20.1	43.9	6.1	26.5	0.0	0.1	0.4	0.9	17.0	2.0	6.4	0.0	3.8	4.6	0.2	0.3	35.3	0.2	1.0	0.0	0.6	0.0	12.1	0.9	0.7	0.0	1.0	0.0	25.8	0.0	0.0	0.1	1.6	2.6	4.1	0.4	2.1	0.0	0.3	0.1	266.9	0.0	0.2	4.1	1.5	26.0	0.1	0.6	0.1	0.6	0.0	0.2	0.3
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;choroid plexus: 15.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA		240000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	1.3	0.8	19.0	0.6	20.5	0.7	0.5	20.6	30.7	1.6	15.2	4.4	0.5	1.8	0.9	0.4	2.5	1.5	2.9	19.4	20.3	0.2	0.1	0.4	0.2	22.8	19.9	0.8	0.3	0.0	1.0	0.2	22.5	2.3	0.5	2.3	1.1	3.2	0.5	0.5	0.9	4.7	21.6	0.5	2.8	10.8	19.4	0.0	0.3	0.0	0.1	2.0	0.8	24.7	0.1	0.0	0.6	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.5	0.2	0.1	3.5	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	17.1	1.8	0.5	0.3	0.2	0.4	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.3	1.2	0.5	0.5	0.3	0.1	0.1	19.0	20.5	20.6	30.7	19.4	20.3	22.8	19.9	22.5	21.6	19.4	24.7	1.3	0.0	3.0	46.4	1.0	3.6	1.1	0.0	0.0	14.5	2.4	3.9	1.3	0.0	0.7	0.0	37.5	0.2	3.3	0.3	0.0	0.3	18.3	0.7	1.7	2.1	1.2	0.0	19.0	0.0	0.4	17.3	1.1	0.4	8.9	0.9	4.2	0.3	0.6	16.8	20.9	0.5	0.0	3.3	2.6	32.3	26.1	3.8	23.2	2.8	1.9	148.3	2.1	102.1	26.4	0.2	0.1	20.7	1.0	1.9	0.4	0.3	0.8	28.3	13.1	2.4	20.3	3.1	2.4	0.1	2.6	0.7	3.1	0.5	0.3	1.0
SERPING1	"C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57619171	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2622.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 726.4;Ductal cells: 604.0;Fibroblasts: 793.6;Hepatocytes: 2530.0;Leydig cells: 735.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 65.2;plasmacytoid DC: 60.6"	"Group enriched"	"Detected in many"	243	"dendritic cells: 60.6;granulocytes: 65.2;monocytes: 25.7"	"Group enriched"	"Detected in many"	6	"ASC diff: 1372.2;ASC TERT1: 694.9;HSkMC: 1159.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 194.1"	"CAB026161, HPA048738"	Supported				"Secreted to blood"	NA	NA		28000000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	971.5	144.2	27.4	90.0	27.5	10.9	733.0	27.1	36.0	629.4	53.4	358.7	52.0	616.7	163.3	162.0	793.2	533.0	547.1	26.2	34.8	337.3	2622.4	785.0	147.6	67.4	34.7	918.3	267.5	55.2	138.2	198.9	34.2	329.3	97.0	34.5	250.5	258.1	151.8	293.5	283.5	226.8	42.3	240.7	344.8	50.6	37.2	36.1	338.2	173.4	64.4	555.9	519.8	35.1	0.0	0.0	48.2	0.0	1372.2	694.9	7.3	74.2	57.0	16.8	30.7	2.5	0.0	0.0	96.7	42.1	0.0	0.0	0.4	4.7	9.4	0.0	0.1	33.7	0.0	1.7	170.3	0.9	5.4	1159.0	15.5	5.7	0.2	6.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.3	46.6	0.0	0.0	4.3	4.0	0.7	7.4	0.0	0.2	14.4	0.3	0.0	0.9	41.8	0.2	3.3	0.0	0.8	21.2	0.7	0.0	0.2	0.4	0.6	0.2	0.5	0.0	0.0	18.3	0.3	0.0	25.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	65.2	0.2	11.5	60.6	0.0	5.7	27.4	27.5	27.1	36.0	26.2	34.8	67.4	34.7	34.2	42.3	37.2	35.1	162.1	118.6	110.8	5.5	8.0	75.8	61.2	7.1	24.5	0.8	24.2	57.7	28.7	726.4	57.5	158.2	0.0	37.1	15.3	0.0	43.0	604.0	4.8	76.0	297.4	150.5	0.0	69.2	3.6	44.0	93.4	793.6	8.6	69.6	7.6	8.3	260.5	2530.0	43.6	0.0	6.2	0.1	2.0	118.9	94.2	25.6	735.3	46.9	90.7	15.9	10.4	57.2	0.0	3.5	0.5	41.4	0.0	228.7	4.5	32.4	0.0	53.5	23.1	4.5	269.5	143.6	259.6	2.5	10.4	9.0	59.5	25.2	16.8	3.4	0.0	37.4
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780591-153789083	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 318.8;urinary bladder: 306.7"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 806.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"AF22: 229.1;ASC diff: 85.2;HSkMC: 140.2;NTERA-2: 318.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	188.2	16.0	4.9	84.6	4.0	0.3	154.9	3.6	6.3	23.2	11.2	72.2	18.4	12.0	22.2	212.7	62.1	318.8	6.2	12.3	13.8	4.5	0.3	62.5	11.8	4.5	3.7	8.3	45.1	7.0	72.5	0.4	4.6	56.5	44.3	2.3	83.4	70.5	6.5	80.5	57.3	89.5	3.8	0.7	34.4	1.5	2.2	9.6	92.3	38.7	3.6	306.7	63.0	12.3	0.0	0.0	229.1	0.2	85.2	15.1	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	140.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	318.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.1	0.1	0.0	8.1	0.2	0.0	0.0	0.4	0.1	0.0	12.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.0	3.6	6.3	12.3	13.8	4.5	3.7	4.6	3.8	2.2	12.3	15.5	3.2	0.6	9.4	0.5	115.5	0.8	0.0	5.7	0.0	3.7	7.9	0.3	0.0	1.9	0.0	0.0	0.1	2.0	0.0	0.0	0.2	0.0	0.1	0.1	11.8	0.0	0.0	0.7	0.0	0.2	806.1	38.7	0.3	1.3	0.0	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.0	175.0	0.5	4.1	5.0	119.2	0.0	0.6	0.0	0.0	0.5	0.1	0.1	0.0	7.2	4.1	0.7	0.0	0.1	2.9	0.0	0.0	6.7	59.4	0.0	0.1	6.9	106.0	0.1	8.6	0.0	0.0	0.9
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142638	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 40.2"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 207.7;Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 72.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enriched"	"Detected in some"	8	"HHSteC: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049124	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA049124: AB_2680643"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	1.6	0.2	1.5	0.2	1.0	0.0	1.1	1.0	1.5	1.4	0.8	1.0	2.3	1.3	0.0	1.2	1.8	5.2	1.6	1.2	1.1	0.4	1.0	0.6	0.1	1.6	1.9	2.4	0.2	0.4	0.1	0.2	1.8	0.8	0.0	40.2	0.5	0.0	1.3	0.8	3.1	0.0	1.5	0.0	0.8	0.5	2.3	0.0	0.6	3.0	0.0	1.0	1.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	1.5	1.0	1.0	1.5	1.2	1.1	1.6	1.9	1.8	1.5	2.3	1.2	1.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	207.7	0.0	0.0	0.6	0.0	0.0	0.0	70.9	0.1	3.0	2.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.2	5.9	4.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	1.0	0.0	0.3	0.0	0.0	1.2	0.5	0.0	7.5	0.0	8.5	16.5	0.0	0.1	0.0	4.0	1.2	0.7	0.0	17.7	0.7	0.0	72.3	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.3	0.0
SNED1	"FLJ00133, Snep, SST3"	ENSG00000162804	"Sushi, nidogen and EGF like domains 1"	Q8TER0	2	240998618-241095568	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 95.0;Excitatory neurons: 86.0;Leydig cells: 95.1;Microglial cells: 77.8;Peritubular cells: 71.1;Skeletal myocytes: 53.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"ASC TERT1: 410.4;HSkMC: 211.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036414, HPA036415"	Uncertain				"Secreted to blood"	NA	NA		27000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA036414: AB_10960852, HPA036415: AB_10964128"	"unprognostic (1.41e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.62e-2)"	"unprognostic (7.77e-4)"	"unprognostic (3.49e-2)"	"unprognostic (4.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.51e-3)"	"unprognostic (4.95e-3)"	23.8	9.3	4.2	6.4	8.5	1.2	15.8	14.1	6.9	34.1	32.4	7.3	4.5	18.0	11.8	6.1	21.6	18.7	11.1	10.7	11.7	7.1	8.0	13.3	4.7	8.3	6.4	21.9	7.3	3.1	7.2	1.9	4.8	12.5	3.4	2.5	14.6	7.5	19.8	12.1	10.4	6.3	0.6	14.1	5.7	9.3	2.2	3.3	30.2	9.1	2.9	11.5	10.7	5.9	0.1	0.6	0.4	4.8	61.1	410.4	0.3	2.4	1.5	0.5	0.2	0.2	0.2	0.1	1.0	4.4	0.5	0.2	0.4	0.0	0.3	2.7	1.0	0.2	4.5	0.4	2.6	0.2	0.5	211.6	0.1	0.5	0.3	28.4	9.5	0.2	0.1	2.7	11.5	2.4	1.6	0.2	0.7	0.1	0.3	0.2	8.1	0.1	5.6	0.5	0.8	0.3	1.9	8.3	4.2	0.6	1.8	0.8	23.7	8.7	0.6	50.9	1.5	0.8	0.4	1.5	11.7	0.1	2.6	0.0	0.0	0.0	0.0	0.3	0.3	1.9	0.4	0.2	0.0	0.6	0.2	0.2	0.0	0.0	0.7	0.0	0.4	0.0	4.2	8.5	14.1	6.9	10.7	11.7	8.3	6.4	4.8	0.6	2.2	5.9	8.0	6.4	11.0	95.0	8.4	3.6	0.9	0.4	2.8	2.8	1.1	1.8	2.4	1.5	8.5	5.5	0.0	0.1	0.3	0.3	0.0	1.2	1.3	10.6	16.8	10.9	2.4	3.2	86.0	1.2	0.1	22.1	2.6	10.7	0.0	5.0	22.9	5.8	0.2	1.7	32.5	0.2	0.0	2.9	5.9	5.9	95.1	2.7	1.8	77.8	0.6	7.4	0.0	11.6	7.0	0.7	0.1	71.1	0.9	3.0	0.0	0.5	4.2	1.2	26.3	53.7	4.9	0.6	1.5	0.7	2.6	0.4	1.8	36.4	0.5	0.6
SRRM3	FLJ37078	ENSG00000177679	"Serine/arginine repetitive matrix 3"		7	76201896-76287288	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"brain: 56.0;retina: 27.2"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 153.1;Cone photoreceptor cells: 479.6;Excitatory neurons: 139.1;Horizontal cells: 171.6;Inhibitory neurons: 144.4;Rod photoreceptor cells: 421.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 10.9;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019337			Approved	"Plasma membrane,Intermediate filaments,Microtubules"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Intermediate filaments, Microtubules"	"HPA019337: AB_1848909"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.15e-2)"	0.0	2.1	6.0	0.1	13.2	0.0	0.0	56.0	30.7	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.0	0.0	0.1	4.8	0.2	0.0	0.0	0.0	0.0	41.5	3.2	0.2	0.3	0.3	8.9	0.0	40.1	0.1	0.1	27.2	0.1	0.0	0.1	0.0	0.1	0.0	1.6	0.0	0.4	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	4.7	0.3	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	8.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	13.2	56.0	30.7	4.8	0.2	41.5	3.2	40.1	1.6	0.9	4.7	0.3	0.0	0.0	8.1	0.0	2.0	6.4	1.9	7.4	153.1	1.8	0.5	6.9	1.5	1.2	0.0	479.6	0.4	0.0	0.2	0.0	2.0	22.2	0.5	4.2	1.2	12.1	0.0	139.1	2.4	8.1	4.8	0.5	1.0	0.0	12.0	1.8	0.0	0.5	171.6	144.4	0.1	2.0	0.0	0.8	32.2	2.1	0.2	3.6	5.6	0.0	15.9	0.0	18.6	4.9	0.9	0.1	2.2	0.0	2.2	0.0	0.4	0.2	421.8	0.0	1.2	2.0	8.6	3.1	4.9	1.1	2.2	0.1	0.2	0.0	4.9
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051480-5500994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.2;Late spermatids: 39.3;Microglial cells: 27.2;Oligodendrocyte precursor cells: 169.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.5;HUVEC TERT2: 27.5;REH: 25.2;U-2197: 43.8;WM-115: 112.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	3.5	0.3	2.3	1.2	7.8	1.5	4.3	1.9	2.3	3.3	1.5	1.1	0.5	3.5	0.3	1.2	1.3	1.4	0.4	2.1	4.5	15.0	0.1	0.9	1.8	3.7	3.9	0.6	1.8	0.3	0.4	3.2	3.7	0.6	1.1	0.8	1.0	0.9	1.3	2.4	1.1	2.5	3.6	0.2	6.0	4.5	3.5	19.5	1.7	1.7	1.0	3.1	1.5	3.6	0.0	14.0	0.8	0.0	0.6	1.0	0.0	9.7	1.1	6.3	0.2	0.1	0.0	0.0	2.1	19.7	27.5	0.1	1.5	0.0	2.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.2	27.5	1.4	0.0	0.1	3.4	0.0	0.0	2.0	4.1	0.0	0.0	25.2	0.1	0.0	6.2	0.0	0.4	0.0	0.0	0.1	8.5	0.6	0.0	0.0	7.1	0.2	2.8	43.8	0.0	0.9	0.1	0.0	0.1	0.0	112.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	7.8	1.9	2.3	2.1	4.5	3.7	3.9	3.7	3.6	3.5	3.6	3.6	0.0	1.1	1.6	0.0	2.3	0.2	0.0	0.0	0.0	4.2	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	17.6	1.1	108.2	0.2	0.1	3.2	0.0	0.0	3.7	0.0	0.1	5.5	4.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	14.4	0.0	0.0	0.0	1.2	39.3	1.5	1.1	5.4	27.2	0.5	0.0	0.0	169.4	1.3	0.4	0.0	1.2	0.0	0.1	0.0	18.9	0.0	0.0	0.0	0.6	0.4	1.2	5.5	0.0	1.0	0.0	0.2	0.4	0.0	0.1
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365248-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 38.6;placenta: 61.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 92.8;Inhibitory neurons: 50.3;Leydig cells: 42.0;Oligodendrocytes: 140.5;Syncytiotrophoblasts: 67.3;Theca cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 147.1;ASC TERT1: 84.7;BJ hTERT+: 62.3;HHSteC: 53.8;HSkMC: 66.7"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 20.8"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"	NA	NA		160000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	38.6	4.2	1.5	2.5	8.6	0.0	23.2	8.9	2.8	10.6	0.9	9.7	1.2	8.6	5.6	3.5	12.4	6.2	6.5	1.1	3.4	3.9	2.9	19.7	3.8	2.7	5.3	3.9	4.7	5.3	0.8	61.7	3.3	1.7	5.1	0.0	4.1	2.1	4.4	11.3	8.7	9.5	1.0	5.2	7.7	1.0	4.3	1.8	7.4	5.5	2.4	9.7	12.1	6.1	0.0	0.1	1.2	0.0	147.1	84.7	0.0	16.3	62.3	1.2	1.9	1.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	12.2	1.0	0.0	0.3	0.1	1.4	0.0	53.8	0.0	2.9	66.7	0.0	12.1	3.2	1.4	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.2	7.5	2.0	0.0	10.6	0.0	0.0	0.0	2.3	0.0	1.0	0.0	1.3	2.5	0.0	7.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	8.6	8.9	2.8	1.1	3.4	2.7	5.3	3.3	1.0	4.3	6.1	7.4	0.0	0.5	2.9	0.1	5.7	0.6	0.5	1.2	0.5	0.4	0.9	1.8	5.7	0.1	0.0	0.0	12.2	0.3	0.0	0.0	0.9	0.3	0.5	13.8	2.0	0.0	0.0	16.9	0.2	1.6	92.8	4.1	0.3	0.0	0.0	2.2	0.0	3.0	0.0	50.3	0.0	0.0	0.0	8.2	0.6	42.0	0.6	7.2	13.1	0.0	0.0	0.0	3.0	140.5	0.0	1.2	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	3.5	7.8	0.4	1.5	0.4	3.3	67.3	1.2	34.1	0.2	0.2
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.3"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	10.3	2.0	1.6	0.9	3.1	0.0	6.1	1.1	3.4	1.9	4.6	0.7	0.1	1.4	0.4	3.1	1.8	1.5	6.6	1.3	1.3	0.4	0.2	0.3	1.8	1.7	1.2	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.7	1.1	0.5	1.5	0.0	0.4	1.0	2.1	0.6	1.7	1.4	0.2	4.5	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.1	3.4	1.3	1.3	1.7	1.2	1.6	1.5	2.1	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 51.2;fallopian tube: 24.6;ovary: 18.5;smooth muscle: 20.4"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 10.5;Peritubular cells: 29.0;Sertoli cells: 52.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"THP-1: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044596			Approved	"Nuclear speckles"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA044596: AB_10797258"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.5	0.4	4.6	0.2	0.2	0.1	51.2	5.8	0.0	24.6	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.1	18.5	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	20.4	0.0	2.3	0.1	2.6	0.2	0.0	0.0	0.0	0.0	0.2	2.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.4	0.3	0.2	1.1	0.3	0.1	0.4	0.1	0.0	0.2	0.2	0.5	0.4	0.3	0.2	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.0	2.2	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.3	0.3	0.7	0.0	0.6	0.0	2.1	0.0	0.2	0.1	0.0	0.0	1.7	0.2	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	1.3	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	10.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.7	0.0	0.1	0.0	0.6	52.6	1.0	1.5	0.3	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.6
TENM3	"KIAA1455, ODZ3, Ten-M3, TEN3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 13.1"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 635.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;BEWO: 63.3;HDLM-2: 90.0;T-47d: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047043	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA047043: AB_2679914"	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	5.0	5.1	12.0	1.6	18.4	0.0	2.0	0.0	12.3	1.5	0.0	4.3	0.8	2.9	0.6	0.8	1.0	2.4	1.4	21.8	8.1	0.9	0.3	0.8	0.8	2.8	7.3	3.8	1.2	5.1	4.5	13.1	0.0	3.7	0.8	3.9	0.6	3.6	2.1	0.4	0.9	2.3	0.8	2.2	0.7	2.1	7.4	2.8	6.1	4.3	1.2	1.6	1.4	2.0	0.3	2.6	66.3	0.4	13.2	23.5	63.3	7.8	2.7	6.9	6.1	33.9	17.6	0.0	0.9	52.6	28.6	3.3	16.0	3.4	6.8	90.0	26.7	0.0	0.0	0.0	1.3	0.0	0.0	31.2	1.2	21.5	15.0	15.4	9.6	0.0	0.0	0.4	10.6	2.3	0.1	0.1	21.4	0.0	2.8	0.0	17.1	0.2	0.1	0.1	27.2	25.2	4.0	0.5	0.1	35.8	86.0	3.4	21.2	53.7	38.2	0.2	39.6	0.0	0.0	0.0	28.2	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	18.4	0.0	12.3	21.8	8.1	2.8	7.3	0.0	0.8	7.4	2.0	0.1	0.0	0.0	23.8	0.0	0.4	0.2	0.7	1.8	50.8	1.6	2.2	3.9	0.0	0.1	3.7	4.2	112.7	0.0	0.0	1.9	0.1	12.4	0.1	4.5	0.7	5.3	0.0	115.6	1.8	54.6	4.1	0.0	0.6	0.0	7.7	1.1	0.7	10.4	5.0	635.6	0.0	0.0	0.0	0.7	3.2	8.4	0.0	1.8	8.4	0.0	10.6	0.0	12.1	24.4	0.4	0.0	2.6	0.0	0.4	0.0	0.3	0.0	3.1	0.0	4.8	3.2	3.8	7.2	1.8	0.0	133.4	0.1	4.1	0.1	0.1
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119415476-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	90.6	16.4	97.9	78.6	114.8	0.2	25.6	12.9	286.8	78.9	0.0	35.4	10.2	58.6	27.8	29.4	23.1	101.0	12.9	135.4	73.3	142.2	7.4	21.6	40.4	83.6	37.0	9.2	14.8	39.4	18.1	62.0	60.8	15.5	41.8	25.3	8.5	47.0	3.4	13.9	14.5	304.7	35.4	21.9	17.4	11.4	43.6	73.2	37.9	8.3	35.6	216.7	21.7	108.7	0.7	3.9	108.5	0.1	461.3	331.5	0.3	738.4	832.5	263.6	289.3	0.2	0.2	0.4	0.1	1330.6	121.9	0.9	4.3	1.1	200.7	65.1	0.0	41.5	14.4	0.0	142.7	0.0	0.2	247.5	0.0	335.6	11.6	355.2	0.3	22.6	0.0	0.6	206.5	0.1	0.6	0.1	173.9	0.0	1.4	0.5	50.7	0.3	0.1	0.2	18.1	47.9	0.1	0.4	0.2	32.9	1.0	2.1	0.0	368.6	120.9	107.3	110.1	0.3	19.7	0.4	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.9	114.8	12.9	286.8	135.4	73.3	83.6	37.0	60.8	35.4	43.6	108.7	68.2	0.0	1.8	17.3	2.1	17.7	0.3	1.7	0.0	27.2	1.6	40.0	0.9	0.0	0.0	9.2	0.0	1.9	0.2	0.0	21.5	0.9	1.0	5.1	141.6	69.2	0.0	0.0	116.0	0.0	2.6	201.9	1.5	3.2	1.3	0.0	17.5	0.1	4.0	32.0	104.1	0.0	0.0	0.0	25.0	2.7	96.3	2.7	17.8	21.5	0.0	108.1	0.0	64.3	22.7	0.4	0.0	77.5	0.1	0.3	0.0	199.9	0.0	27.5	32.9	9.3	226.6	0.3	0.6	0.2	17.6	4.0	4.5	6.2	0.0	0.6
TPBG	"5T4, 5T4-AG"	ENSG00000146242	"Trophoblast glycoprotein"	Q13641	6	82363206-82367420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.6;hTCEpi: 115.2;hTEC/SVTERT24-B: 98.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010554	Enhanced		Approved	Nucleoplasm		NA	NA		310000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA010554: AB_1858206"	"unprognostic (3.03e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.55e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.57e-2)"	19.9	2.5	1.6	3.3	20.6	0.5	17.3	0.4	5.7	24.2	0.6	8.5	3.5	15.8	2.6	26.3	14.9	6.9	9.1	0.2	4.2	10.7	1.5	7.5	1.9	8.2	11.4	6.0	8.3	4.2	14.2	6.2	9.3	15.3	3.0	0.2	20.1	7.0	2.9	15.9	8.0	6.7	3.1	9.9	9.0	3.6	3.6	4.2	15.7	1.9	3.0	35.1	20.2	3.6	17.1	27.6	8.7	21.2	35.2	40.4	17.6	84.9	94.6	16.7	22.0	3.9	26.9	0.0	9.6	39.5	51.9	37.3	10.3	44.6	13.9	0.0	14.5	11.9	13.1	0.8	29.1	0.9	9.2	25.8	115.2	98.5	34.1	12.9	4.5	0.7	2.3	0.2	3.9	37.8	0.0	0.0	12.5	8.8	22.3	0.0	19.4	0.2	24.4	25.8	4.4	16.9	20.9	28.3	0.0	16.2	49.4	3.5	10.8	15.1	15.8	33.5	19.2	0.1	0.0	0.0	71.3	1.3	17.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	20.6	0.4	5.7	0.2	4.2	8.2	11.4	9.3	3.1	3.6	3.6	16.4	12.8	6.5	2.3	0.2	67.9	78.2	120.3	68.3	1.1	44.6	24.0	2.1	21.5	62.4	55.2	0.0	42.7	0.4	9.0	0.0	35.8	8.6	29.2	38.7	25.4	1.2	0.0	21.3	45.4	82.5	48.0	14.8	68.0	0.0	3.8	11.0	0.2	3.6	1.7	0.9	20.2	75.3	0.6	11.5	6.5	12.8	2.3	17.8	7.5	0.1	2.1	0.0	2.0	3.2	38.2	17.8	6.0	0.0	51.9	1.9	0.7	29.9	0.3	32.9	55.6	47.0	13.7	11.8	25.2	31.3	65.9	3.5	9.7	10.8	78.8
VIT		ENSG00000205221	Vitrin	Q6UXI7	2	36696690-36814792	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.4;tongue: 41.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 68.3;Fibroblasts: 58.8;Granulosa cells: 45.1;Leydig cells: 115.2;Skeletal myocytes: 45.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.3;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 33.6;ASC TERT1: 65.2;BJ: 32.9;fHDF/TERT166: 112.3;SuSa: 62.2;THP-1: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		140000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (5.34e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.78e-3)"	"unprognostic (8.32e-2)"		"unprognostic (1.81e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.66e-6)"	"unprognostic (2.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.41e-2)"	35.4	0.9	0.2	0.5	0.5	0.9	15.4	0.8	0.9	6.0	0.4	3.9	0.4	1.0	0.6	8.7	7.9	2.3	18.6	0.3	0.1	0.2	0.0	1.2	2.3	0.1	0.1	28.7	1.0	0.6	3.1	2.2	0.1	7.0	1.5	0.0	11.6	2.3	12.5	12.7	2.7	0.2	0.0	0.1	4.7	3.0	0.3	1.0	8.9	41.1	2.2	15.0	14.6	0.2	0.0	0.0	0.0	0.0	33.6	65.2	0.0	32.9	7.7	10.4	4.3	0.0	0.0	0.0	0.0	112.3	0.1	0.2	6.2	0.0	6.9	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	3.3	1.6	0.0	0.0	0.0	2.5	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.7	0.0	62.2	0.0	35.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	2.5	2.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.5	0.8	0.9	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.2	4.1	0.0	0.0	0.7	0.0	4.2	0.9	0.0	68.3	0.0	0.2	10.0	3.2	0.0	0.0	0.0	0.0	10.6	0.9	0.3	0.0	0.0	1.2	0.4	0.4	1.1	0.0	0.0	1.8	0.0	11.0	58.8	0.0	0.0	0.0	45.1	0.4	0.0	1.1	0.0	0.7	0.4	0.0	0.0	3.5	2.7	115.2	0.5	7.2	20.6	0.0	0.0	4.1	0.5	0.3	0.0	0.1	23.3	0.8	0.1	0.0	0.0	0.0	0.0	6.6	45.2	6.1	1.1	0.6	1.6	3.4	4.2	1.1	0.1	0.3	0.2